Section 9

EurekaMag PDF full texts Chapter 8,800


Huang, R.; Nakazono, N.; Ishii, K.; Li, D.; Kawamata, O.; Kawaguchi, R.; Tsukada, Y. 1995: I. Hepatitis E virus (87A strain) propagated in A549 cells. Journal of Medical Virology 47(4): 299-302
Arala-Chaves, M.; Vilanova, M.; Ribeiro, A.; Pinto, J. 1994: Immunostimulatory effect of thalidomide in normal C57BL/6 mice is compatible with stimulation of a highly connected central immune system. Scandinavian Journal of Immunology 40(5): 535-542
Kim, S.Y.; Silver, M.R.; Decoursey, T.E. 1996: Ion channels in human THP-1 monocytes. Journal of Membrane Biology 152(2): 117-130
Tallman, J.F.; Primus, R.J.; Brodbeck, R.; Cornfield, L.; Meade, R.; Woodruff, K.; Ross, P.; Thurkauf, A.; Gallager, D.W. 1997: I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. Journal of Pharmacology and Experimental Therapeutics 282(2): 1011-1019
Ishay, J., S.; Barenholz-Paniry, V.; Bitler, A. 1997: I. On hornet silk as a photodetector: Considerations of current, voltage and resistance. Physiological Chemistry and Physics and Medical NMR 29(1): 95-108
Lange, K.A.; Ovsyannikov, V.I. 1996: I. P. Pavlov: At the Imperial Institute of Experimental Medicine and his contribution to the physiology of digestion. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1996(1): 11-16
Linton, S.J. 1997: I. Psychological interventions for patients with chronic back pain. Medicina (Ribeirao Preto) 30(2): 289-301
Van-Loey, A.M.; Haentjens, T.H.; Hendrickx, M.E.; Tobback, P.P. 1997: I. The development of an enzymic time temperature integrator to assess thermal efficacy of sterilization of low-acid canned foods. Food Biotechnology (New York) 11(2): 147-168
Anton'ev, A.A.; Rakhimova-Belova, L.V. 1993: I.I. Metchnikoff's contribution to syphilidology. Vestnik Dermatologii i Venerologii 1993(6): 56-61
Palma, E.; Di-Marzio, G.; Pizzicoli, P.; Capone, P.; Sampaolo, P.; Capotorto, B.; Spada, S.; Procaccini, D.; Battistelli, L.; Scipioni, G. 1996: I.O.P. Monitoring before and after dialysis. Annali di Ottalmologia e Clinica Oculistica 122(5): 313-324
Doyle, E.; McFadzean, W.; Morton, N.S. 1993: IV anaesthesia with propofol using a target-controlled infusion system: comparison with inhalation anaesthesia for general surgical procedures in children. British Journal of Anaesthesia 70(5): 542-545
Huang, Y.F.; Upton, R.N.; Runciman, W.B. 1993: IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: relationships between myocardial pharmacokinetics and pharmacodynamics. British Journal of Anaesthesia 70(5): 556-561
Pettit, H.O.; Lutz, D.; Gutierrez, C.; Eveleth, D. 1994: I.c.v. infusions of ACPD(1S,3R) attenuate learning in a Morris water maze paradigm. Neuroscience Letters 178(1): 43-46
Matsukawa, T.; Hanagata, K.; Ozaki, M.; Iwashita, H.; Koshimizu, M.; Kumazawa, T. 1997: I.m. midazolam as premedication produces a concentration-dependent decrease in core temperature in male volunteers. British Journal of Anaesthesia 78(4): 396-399
Capogna, G.; Celleno, D. 1993: IV clonidine for post-extradural shivering in parturients: a preliminary study. British Journal of Anaesthesia 71(2): 294-295
Vijn, P.C.; Sneyd, J.R. 1998: I.v. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions. British Journal of Anaesthesia 81(3): 415-421
Hirota, K.; Lambert, D.G. 1996: I.v. anaesthetic agents do not interact with the verapamil binding site on L-type voltage-sensitive Ca2+ channels. British Journal of Anaesthesia 77(3): 385-386
Hirota, K.; Lambert, D.G. 1996: I.v. anaesthetic agents inhibit dihydropyridine binding to L-type voltage-sensitive Ca2+ channels in rat cerebrocortical membranes. British Journal of Anaesthesia 77(2): 248-253
Huang, Y.F.; Upton, R.N.; Runciman, W.B. 1993: IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: myocardial pharmacokinetics. British Journal of Anaesthesia 70(3): 326-332
Sia, S. 1998: I.v. clonidine prevents post-extradural shivering. British Journal of Anaesthesia 81(2): 145-146
Wajima, Z.; Nakajima, Y.; Kim, C.; Kobayashi, N.; Kadotani, H.; Adachi, H.; Inoue, T.; Ogawa, R. 1995: IV compared with brachial plexus infusion of butorphanol for postoperative analgesia. British Journal of Anaesthesia 74(4): 392-395
Nikanne, E.; Kokki, H.; Tuovinen, K. 1997: IV perioperative ketoprofen in small children during adenoidectomy. British Journal of Anaesthesia 78(1): 24-27
Elhakim, M.; Nafie, M. 1995: I.v. tenoxicam for analgesia during caesarean section. British Journal of Anaesthesia 74(6): 643-646
Haxhiu, M.A.; Dreshaj, I.A.; Mcfadden, C.B.; Erokwu, B.O.; Ernsberger, P. 1998: I1-imidazoline receptors and cholinergic outflow to the airways. Journal of the Autonomic Nervous System 71(2-3): 167-174
Bousquet, P.; Dontenwill, M.; Greney, H.; Feldman, J. 1998: I1-imidazoline receptors: an update. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 16(3): S1-S5
Jin, L.; Yao, J.; Zhao, C.; Gao, P.; Li, S. 1994: I2190B, an immunosuppressant, isolation and identification. Zhongguo Kangshengsu Zazhi 19(5): 323-327
Johansen, S.; Rask-Pedersen, E.; Prause, J.U. 1996: A bioavailability comparison in rabbits after a single topical ocular application of prednisolone acetate formulated as a high-viscosity gel and as an aqueous suspension. Acta Ophthalmologica Scandinavica 74(3): 253-258
Van Roy, N.; Laureys, G.; Cheng, N.C.; Willem, P.; Opdenakker, G.; Versteeg, R.; Speleman, F. 1994: 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes and Cancer 10(2): 103-114
Lan, M.S.; Russell, E.K.; Lu, J.; Johnson, B.E.; Notkins, A.L. 1993: IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Research 53(18): 4169-4171
Savola, K.; Bonifacio, E.; Sabbah, E.; Kulmala, P.; Vahasalo, P.; Karjalainen, J.; Tuomilehto Wolf, E.; Merilainen, J.; Akerblom, H.K.; Knip, M.; Group, C.D.abetes I.F.nland Study 1998: IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 41(4): 424-429
Lan, M.S.; Wasserfall, C.; Maclaren, N.K.; Notkins, A.L. 1996: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America 93(13): 6367-6370
Xie, H.; Notkins, A.L.; Lan, M.S. 1996: IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype. Cancer Research 56(12): 2742-2744
Kim, D.-Gyoon; Kim, M.-Won; Kang, Y.-Hee 1992: IAA synthesis and polyamine metabolism in higher plants: Effect of IAA on the activity of diamine oxidase in seedlings of soybean. Korean Journal of Botany 35(3): 265-271
Merkys, A.; Saviciene, E. 1991: IAA synthesis, transport and metabolism in beans (Phaseolus vulgaris L.) and the role of the leaf in supplying a plant with IAA. Eksperimentine Biologija 1991(4): 57-70
Darginavichene, Y.V.; Merkis, A.I.; Ulyavichene, R.R.; Zhyamenas, I.A.; Maksimov, G.B. 1992: IAA-binding properties of the plasmalemma from wheat coleoptiles. Fiziologiya Rastenii 39(2): 249-258
Pompeu, Antonio-Sidney 1997: IAC-Maravilha, IAC-Una, IAC-Carioca Pyata, IAC-Carioca Arua, IAC-Carioca Akyta and IAC-Bico de Ouro: New dry bean cultivars. Bragantia 56(1): 79-85
Felicio, J.-Carlos; Camargo, C.-Eduardo-De-Oliveira; Ferreira-Filho, A.-Wilson-Penteado; Gallo, P.-Boller; Ramos, V.-Josue; Vitti, P. 1991: IAC60 Centenario and IAC 162 Tuiuiu: Wheat cultivars for upland and irrigated conditions in the state of Sao Paulo, Brazil. Bragantia 50(2): 291-307
Parr, R.M.; Fajgelj, A.; Dekner, R.; Ruiz, H.V.; Carvalho, F.P.; Povinec, P.P. 1998: IAEA analytical quality assurance programmes to meet the present and future needs of developing countries. Fresenius' Journal Of Analytical Chemistry. 360(3-4): 287-290,.
Sengupta, S.; Clayton, P.D.; Molholt, P.; Sideli, R.V.; Cimino, J.J.; Hripcsak, G.; Johnson, S.B.; Allen, B.; Mccormack, M.; Hill, C. 1994: IAIMS and sharing. International Journal of Bio-Medical Computing 34(1-4): 339-348
Pidgeon, C.; Ong, S.; Liu, H.; Qiu, X.; Pidgeon, M.; Dantzig, A.H.; Munroe, J.; Hornback, W.J.; Kasher, J.S.; Glunz, L. 1995: IAM chromatography: An in vitro screen for predicting drug membrane permeability. Journal of Medicinal Chemistry 38(4): 590-594
Ducarne, A.; Neuwels, M.; Goldstein, S.; Massingham, R. 1998: IAM retention and blood brain barrier penetration. European Journal of Medicinal Chemistry 33(3): 215-223
Dupressoir, A.; Puech, A.; Heidmann, T. 1995: IAP retrotransposons in the mouse liver as reporters of ageing. Biochimica Et Biophysica Acta 1264(3): 397-402
Deveraux, Q.L.; Roy, N.; Stennicke, H.R.; Van Arsdale, T.; Zhou, Q.; Srinivasula, S.M.; Alnemri, E.S.; Salvesen, G.S.; Reed, J.C. 1998: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO Journal 17(8): 2215-2223
Hainaut, P.; Hernandez, T.; Robinson, A.; Rodriguez-Tome, P.; Flores, T.; Hollstein, M.; Harris, C.C.; Montesano, R. 1998: IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Research 26(1): 205-213
Bonny, C.; Nicod, P.; Waeber, G. 1998: IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. Journal of Biological Chemistry 273(4): 1843-1846
Bednar, M.M.; Wright, S.D.; Raymond-Russell, S.J.; Kohut, J.J.; Gross, C.E. 1996: IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbit. Neurological Research 18(2): 171-175
Molliver, D.C.; Wright, D.E.; Leitner, M.L.; Parsadanian, A.S.; Doster, K.; Wen, D.; Yan, Q.; Snider, W.D. 1997: IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life. Neuron 19(4): 849-861
Das, S.; Barman, N.N.; Gohain, A.; Sharma, K.; Sarma, D.K. 1996: IBDV infection inducing immunosuppression in NDV-vaccinated broiler chicken. Indian Journal of Animal Sciences 66(8): 753-754
Flifla, M.J.; Garreau, M.; Rolland, J.P.; Coatrieux, J.L.; Thomas, D. 1992: IBIS integrated biological imaging system: electron micrograph image-processing software running on Unix workstations. Computer Applications in the Biosciences: Cabios 8(6): 583-586
Rolland, J.P.; Flifla, M.J.; Garreau, M.; Thomas, D. 1996: IBIS version 3: an OSF/Motif-based interface for IBIS--integrated biological imaging system. Computer Applications in the Biosciences: Cabios 12(3): 241-245
Kaminsky, Y.u.; Bures, J.; Kittlerová, P.; Krekule, I. 1993: IBM PC based visual evoked potential stimulator and averager. Physiological Research 42(1): 41-44
Rowlings, P.A.; Przepiorka, D.; Klein, J.P.; Gale, R.P.; Passweg, J.R.; Henslee-Downey, P.J.; Cahn, J.Y.; Calderwood, S.; Gratwohl, A.; Socié, G.; Abecasis, M.M.; Sobocinski, K.A.; Zhang, M.J.; Horowitz, M.M. 1997: IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. British Journal of Haematology 97(4): 855-864
Usachev, Y.; Verkhratsky, A. 1995: IBMX induces calcium release from intracellular stores in rat sensory neurones. Cell Calcium 17(3): 197-206
Cross, R.J.; Fautrier, A.G.; McNeil, D.L. 1992: IBPGR morphological descriptors - their relevance in determining patterns within a diverse spring barley germplasm collection. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 85(4): 489-495
Tissingh, G.; Booij, J.; Winogrodzka, A.; van Royen, E.A.; Wolters, E.C. 1997: IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism. Journal of Neural Transmission. Supplementum 50: 31-37
Wakai, S.; Sato, A.; Okuhata, S.; Nagai, M. 1995: IC-PC aneurysm causing oculomotor nerve palsy 6 years after SAH then considered to be of unknown etiology. Dokkyo Journal of Medical Sciences 22(4): 263-265
Ueno, M.; Amemiya, M.; Someno, T.; Masuda, T.; Iinuma, H.; Naganawa, H.; Hamada, M.; Ishizuka, M.; Takeuchi, T. 1993: IC101, extracellular matrix antagonist produced by Streptomyces sp. MJ202-72F3. Production, isolation, structure determination and biological activity. Journal of Antibiotics 46(11): 1658-1665
Solimena, M.; Dirkx, R.; Hermel, J.M.; Pleasic-Williams, S.; Shapiro, J.A.; Caron, L.; Rabin, D.U. 1996: ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO Journal 15(9): 2102-2114
Kida, K.; Mimura, G.; Kobayashi, T.; Matsuura, N.; Toyota, T.; Kitagawa, T.; Hibi, I.; Ikeda, Y.; Tuchida, I.; Kuzuya, H. 1994: ICA and organ-specific autoantibodies among Japanese patients with early-onset insulin-dependent diabetes mellitus--the JDS study. Diabetes Research and Clinical Practice 23(3): 187-193
Kamoi, K.; Soga, N.; Takagi, M. 1996: ICA-positive diabetes mellitus with pernicious anemia in an elderly woman. Journal of the Japan Diabetes Society 39(1): 47-51
Gaedigk, R.; Duncan, A.M.; Miyazaki, I.; Robinson, B.H.; Dosch, H.M. 1994: ICA1 encoding p69, a protein linked to the development of type 1 diabetes, maps to human chromosome 7p22. Cytogenetics and Cell Genetics 66(4): 274-276
Gianani, R.; Rabin, D.U.; Verge, C.F.; Yu, L.; Babu, S.R.; Pietropaolo, M.; Eisenbarth, G.S. 1995: ICA512 autoantibody radioassay. Diabetes 44(11): 1340-1344
Mally, M.I.; Cirulli, V.; Hayek, A.; Otonkoski, T. 1996: ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia 39(4): 474-480
Smith, P.D.; Barker, K.T.; Wang, J.; Lu, Y.J.; Shipley, J.; Crompton, M.R. 1996: ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins. Biochemical and Biophysical Research Communications 229(2): 402-411
Samejima, K.; Earnshaw, W.C. 1998: ICAD/DFF regulator of apoptotic nuclease is nuclear. Experimental Cell Research 243(2): 453-459
Defazio, G.; Trojano, M.; Ribatti, D.; Nico, B.; Giorelli, M.; De Salvia, R.; Russo, G.; Roncali, L.; Livrea, P. 1998: ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha. Journal of Neuroimmunology 88(1-2): 13-20
Dennig, D.; Lacerda, J.; Yan, Y.; Gasparetto, C.; O'Reilly, R.J. 1994: ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7. Cellular Immunology 156(2): 414-423
Chong, A.S.; Jiang, X.L.; Scuderi, P.; Lamas, M.; Graf, L.H. 1994: ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Cancer Immunology Immunotherapy: Cii 39(2): 127-134
Morise, Z.; Komatsu, S.; Fuseler, J.W.; Granger, D.N.; Perry, M.; Issekutz, A.C.; Grisham, M.B. 1998: ICAM-1 and P-selectin expression in a model of NSAID-induced gastropathy. American Journal of Physiology 274(2): G246-G252
Molossi, S.; Clausell, N.; Sett, S.; Rabinovitch, M. 1995: ICAM-1 and VCAM-1 expression in accelerated cardiac allograft arteriopathy and myocardial rejection are influenced differently by cyclosporine A and tumour necrosis factor-alpha blockade. Journal of Pathology 176(2): 175-182
d'Alessio, P.; Moutet, M.; Coudrier, E.; Darquenne, S.; Chaudiere, J. 1998: ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic. Free Radical Biology and Medicine 24(6): 979-987
Ramaswamy, K.; He, Y.X.; Salafsky, B. 1997: ICAM-1 and iNOS expression increased in the skin of mice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni. Experimental Parasitology 86(2): 118-132
Guzman, J.; Izumi, T.; Nagai, S.; Costabel, U. 1994: ICAM-1 and integrin expression on isolated human alveolar type II pneumocytes. European Respiratory Journal 7(4): 736-739
Lindsherg, P.J. 1996: ICAM-1 as a potential target for treatments blocking the host response in stroke. Keio Journal of Medicine 45(3): 254-61; Discussion 261-2
Labuda, T.; Wendt, J.; Hedlund, G.; Dohlsten, M. 1998: ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cells. Immunology 94(4): 496-502
Soriano, S.G.; Wang, Y.F.; Lipton, S.A.; Dikkes, P.; Gutierrez-Ramos, J.C.; Hickey, P.R. 1998: ICAM-1 dependent pathway is not involved in the development of neuronal apoptosis after transient focal cerebral ischemia. Brain Research 780(2): 337-341
Arnold, R.; Konig, W. 1996: ICAM-1 expression and low-molecular-weight G-protein activation of human bronchial epithelial cells (A549) infected with RSV. Journal of Leukocyte Biology 60(6): 766-771
Melis, M.; Spatafora, M.; Melodia, A.; Pace, E.; Gjomarkaj, M.; Merendino, A.M.; Bonsignore, G. 1996: ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells. European Respiratory Journal 9(9): 1831-1838
Ohno, A.; Mochida, S.; Arai, M.; Fujiwara, K. 1995: ICAM-1 expression in hepatocytes following dissociation of cell-to-cell contact in rats. Biochemical and Biophysical Research Communications 214(3): 1225-1231
Chow, J.; Hartley, R.B.; Jagger, C.; Dilly, S.A. 1992: ICAM-1 expression in renal disease. Journal of Clinical Pathology 45(10): 880-884
Demoly, P.; Sahla, M.; Campbell, A.M.; Bousquet, J.; Crampette, L. 1998: ICAM-1 expression in upper respiratory mucosa is differentially related to eosinophil and neutrophil inflammation according to the allergic status. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 28(6): 731-738
Pilewski, J.M.; Sott, D.J.; Wilson, J.M.; Albelda, S.M. 1995: ICAM-1 expression on bronchial epithelium after recombinant adenovirus infection. American Journal of Respiratory Cell and Molecular Biology 12(2): 142-148
Hayasaki, Y.; Nakajima, M.; Kitano, Y.; Iwasaki, T.; Shimamura, T.; Iwaki, K. 1996: ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specific endothelin receptor subtype. Biochemical and Biophysical Research Communications 229(3): 817-824
Hess, D.C.; Bhutwala, T.; Sheppard, J.C.; Zhao, W.; Smith, J. 1994: ICAM-1 expression on human brain microvascular endothelial cells. Neuroscience Letters 168(1-2): 201-204
Matsunaga, T.; Katayama, I.; Yokozeki, H.; Nishioka, K. 1996: ICAM-1 expression on keratinocytes in mechanically-injured skin of a patient with atopic dermatitis. Journal of Dermatological Science 12(3): 219-226
Burno, D.K.; Fabian, D.F.; Lefor, A.T. 1996: ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma. Journal of Surgical Research 60(2): 398-402
Olschowka, J.A.; Kyrkanides, S.; Harvey, B.K.; O'Banion, M.K.; Williams, J.P.; Rubin, P.; Hansen, J.T. 1997: ICAM-1 induction in the mouse CNS following irradiation. Brain Behavior and Immunity 11(4): 273-285
Lautenschlager, I.T.; Höckerstedt, K.A. 1993: ICAM-1 induction on hepatocytes as a marker for immune activation of acute liver allograft rejection. Transplantation 56(6): 1495-1499
Gonzalo, J.A.; Martinez, C.; Springer, T.A.; Gutierrez-Ramos, J.C. 1995: ICAM-1 is required for T cell proliferation but not for anergy or apoptosis induced by Staphylococcus aureus enterotoxin B in vivo. International Immunology 7(10): 1691-1698
De Luca, D.J.; Trefzer, U.; Tubesing, K.A.; Elmets, C.A. 1997: ICAM-1 mRNA levels and relative transcription rates are decreased by UV irradiation of monocytes. Photochemistry and Photobiology 65(4): 609-615
Smith, R.J.; Chosay, J.G.; Dunn, C.J.; Manning, A.M.; Justen, J.M. 1996: ICAM-1 mediates leukocyte-endothelium adhesive interactions in the reversed passive Arthus reaction. Journal of Leukocyte Biology 59(3): 333-340
Pizzolo, G.; Vinante, F.; Nadali, G.; Ricetti, M.M.; Morosato, L.; Marrocchella, R.; Vincenzi, C.; Semenzato, G.; Chilosi, M. 1993: ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease. British Journal of Haematology 84(1): 161-162
Flipo, R.M.; Cardon, T.; Copin, M.C.; Vandecandelaere, M.; Duquesnoy, B.; Janin, A. 1997: ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis. Annals of the Rheumatic Diseases 56(1): 41-44
Steffen, B.J.; Breier, G.; Butcher, E.C.; Schulz, M.; Engelhardt, B. 1996: ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. American Journal of Pathology 148(6): 1819-1838
Hornef, M.W.; Bein, G.; Wilhelm, D.; Fricke, L.; Kirchner, H. 1997: ICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation. Clinical and Diagnostic Laboratory Immunology 4(5): 545-549
Fan, X.; Benz, P.; Wüthrich, R.P. 1996: ICAM-1-, -2- and LFA-1-independent homotypic T cell aggregation induced by a novel activating monoclonal antibody targeting the murine Thy-1 molecule. Inflammation 20(4): 401-411
Barnett, C.C.; Moore, E.E.; Mierau, G.W.; Partrick, D.A.; Biffl, W.L.; Elzi, D.J.; Silliman, C.C. 1998: ICAM-1-CD18 interaction mediates neutrophil cytotoxicity through protease release. American Journal of Physiology 274(6): C1634-C1644
Willenborg, D.O.; Simmons, R.D.; Tamatani, T.; Miyasaka, M. 1993: ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system. Journal of Neuroimmunology 45(1-2): 147-154
Takeuchi, Y.; Sakurai, K.; Ike, I.; Yoshie, H.; Kawasaki, K.; Hara, K. 1995: ICAM-1-expressing pocket epithelium, LFA-1-expressing T cells in gingival tissue and gingival crevicular fluid as features characterizing inflammatory cell invasion and exudation in adult periodontitis. Journal of Periodontal Research 30(6): 426-435
Tosi, M.F.; Hamedani, A.; Brosovich, J.; Alpert, S.E. 1994: ICAM-1-independent, CD18-dependent adhesion between neutrophils and human airway epithelial cells exposed in vitro to ozone. Journal of Immunology 152(4): 1935-1942
Xiao, J.; Garcia-Lloret, M.; Winkler-Lowen, B.; Miller, R.; Simpson, K.; Guilbert, L.J. 1997: ICAM-1-mediated adhesion of peripheral blood monocytes to the maternal surface of placental syncytiotrophoblasts: implications for placental villitis. American Journal of Pathology 150(5): 1845-1860
Seidel, M.F.; Keck, R.; Vetter, H. 1997: ICAM-1/LFA-1 expression in acute osteodestructive joint lesions in collagen-induced arthritis in rats. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 45(9): 1247-1253
Mesri, M.; Liversidge, J.; Forrester, J.V. 1994: ICAM-1/LFA-1 interactions in T-lymphocyte activation and adhesion to cells of the blood-retina barrier in the rat. Immunology 83(1): 52-57
Carpenito, C.; Pyszniak, A.M.; Takei, F. 1997: ICAM-2 provides a costimulatory signal for T cell stimulation by allogeneic class II MHC. Scandinavian Journal of Immunology 45(3): 248-254
Doussis-Anagnostopoulou, I.; Kaklamanis, L.; Cordell, J.; Jones, M.; Turley, H.; Pulford, K.; Simmons, D.; Mason, D.; Gatter, K. 1993: ICAM-3 expression on endothelium in lymphoid malignancy. American Journal of Pathology 143(4): 1040-1043
Campanero, M.R.; del Pozo, M.A.; Arroyo, A.G.; Sánchez-Mateos, P.; Hernández-Caselles, T.; Craig, A.; Pulido, R.; Sánchez-Madrid, F. 1993: ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. Journal of Cell Biology 123(4): 1007-1016
Campanero, M.R.; Sánchez-Mateos, P.; del Pozo, M.A.; Sánchez-Madrid, F. 1994: ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands. Journal of Cell Biology 127(3): 867-878
Hernandez-Caselles, T.; Rubio, G.; Campanero, M.R.; del Pozo, M.A.; Muro, M.; Sanchez-Madrid, F.; Aparicio, P. 1993: ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. European Journal of Immunology 23(11): 2799-2806
del Pozo, M.A.; Cabañas, C.; Montoya, M.C.; Ager, A.; Sánchez-Mateos, P.; Sánchez-Madrid, F. 1997: ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes. Journal of Cell Biology 137(2): 493-508
Chang, D.D.; Wong, C.; Smith, H.; Liu, J. 1997: ICAP-1, a novel beta1 integrin cytoplasmic domain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. Journal of Cell Biology 138(5): 1149-1157
Andren, O.; Katterer, T. 1997: ICBM: The introductory carbon balance model for exploration of soil carbon balances. Ecological Applications 7(4): 1226-1236
Brodman, R.F.; Furman, S.; Fell, S.C.; Foxx, M.J.; Frame, R.A.; Fisher, J.D.; Kim, S.G.; Roth, J.A.; Ferrick, K.J. 1994: ICD implantation via thoracoscopy, "mailslot" thoracotomy, and subxiphoid incision. Annals of Thoracic Surgery 57(2): 475-476
Grimm, M.; Grimm, G.; Zuckermann, A.; Wieselthaler, G.; Feuerstein, M.; Daneschvar, H.; Schmiedinger, H.; Schreiner, W.; Wolner, E.; Laufer, G. 1995: ICD therapy in survivors of sudden cardiac death awaiting heart transplantation. Annals of Thoracic Surgery 59(4): 916-920
Janca, A.; Isaac, M. 1997: ICD-10 and DSM-IV symptoms of somatoform disorders in different cultures. Keio Journal of Medicine 46(3): 128-131
Grant, B.F. 1993: ICD-10 and proposed DSM-IV harmful use of alcohol/alcohol abuse and dependence, United States 1988: a nosological comparison. Alcoholism Clinical and Experimental Research 17(5): 1093-1101
Grant, B.F. 1993: ICD-10 harmful use of alcohol and the alcohol dependence syndrome: Prevalence and implications. Addiction 88(3): 413-420
Christensen, H.; Henderson, A.S.; Korten, A.E.; Jorm, A.F.; Jacomb, P.A.; Mackinnon, A.J. 1997: ICD-10 mild cognitive disorder: Its outcome three years later. International Journal of Geriatric Psychiatry 12(5): 581-586
Thomsen, P.H.; Jorgensen, J.; Nedergaard, N.J. 1992: ICD-10: A field study in a Danish child psychiatric unit. European Psychiatry 7(6): 287-291
Brode, S.E.; Schwartzman, D.; Callans, D.J.; Gottlieb, C.D.; Marchlinski, F.E. 1997: ICD-antiarrhythmic drug and ICD-pacemaker interactions. Journal of Cardiovascular Electrophysiology 8(7): 830-842
Wiedemann, G.J. 1998: ICE (ifosfamide, carboplatin, etoposide) chemotherapy and systemic hyperthermia. Onkologie 21(Suppl 2): 10-11
Camps, C.; Vicent, J.M.; Berrocal, A.; Godes, M.; Cuevas, J. 1995: ICE combination therapy in advanced non-small cell lung cancer. Oncologia 18(9): 38-41
Rouquet, N.; Pagès, J.C.; Molina, T.; Briand, P.; Joulin, V. 1996: ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Current Biology: Cb 6(9): 1192-1195
Giegel, D.A. 1997: ICE processing and kinetic mechanism. Journal of Cellular Biochemistry 64(1): 11-18
Duan, H.; Chinnaiyan, A.M.; Hudson, P.L.; Wing, J.P.; He, W.W.; Dixit, V.M. 1996: ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. Journal of Biological Chemistry 271(3): 1621-1625
Duan, H.; Orth, K.; Chinnaiyan, A.M.; Poirier, G.G.; Froelich, C.J.; He, W.W.; Dixit, V.M. 1996: ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. Journal of Biological Chemistry 271(28): 16720-16724
Choi, K.S.; Lim, I.K.; Brady, J.N.; Kim, S.J. 1998: ICE-like protease (caspase) is involved in transforming growth factor beta1-mediated apoptosis in FaO rat hepatoma cell line. Hepatology 27(2): 415-421
Künstle, G.; Leist, M.; Uhlig, S.; Revesz, L.; Feifel, R.; MacKenzie, A.; Wendel, A. 1997: ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunology Letters 55(1): 5-10
Hisahara, S.; Shoji, S.; Okano, H.; Miura, M. 1997: ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. Journal of Neurochemistry 69(1): 10-20
Hatakeyama, S.; Ishikawa, F. 1997: ICE: A novel and efficient method for isolation of chromosomal ends. Genetic Analysis: Biomolecular Engineering 14(2): 45-46
Balls, P.; Cofino, W.; Schmidt, D.; Topping, G.; Wilson, S.; Yeats, P. 1993: ICES baseline survey of trace metals in European shelf waters. ICES (International Council for the Exploration of the Sea) Journal of Marine Science 50(4): 435-444
Brown, D.C.; Grace, E.; Sumner, A.T.; Edmunds, A.T.; Ellis, P.M. 1995: ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): Investigation of heterochromatin abnormalities and review of clinical outcome. Human Genetics 96(4): 411-416
Atmaca, L.S.; Batioğlu, F.; Atmaca, P. 1997: ICG videoangiography of occult choroidal neovascularization in age-related macular degeneration. Acta Ophthalmologica Scandinavica 75(1): 44-47
Aono, J.; Furuno, K.; Ueda, W.; Manabe, M. 1994: ICG-disappearance rate during sevoflurane- or neurolept anesthesia. Masui. Japanese Journal of Anesthesiology 43(6): 894-897
Pires, J.G.; Ramage, A.G.; Jacobs, M. 1993: ICI 169,369, A 5-HT2/5-HT1C antagonist, that can evoke endothelium-dependent relaxation in rabbit aorta. Journal of Autonomic Pharmacology 13(4): 249-255
Wade, G.N.; Powers, J.B.; Blaustein, J.D.; Green, D.E. 1993: ICi 182,780 antagonizes the effects of estradiol on estrous behavior and energy balance in Syrian hamsters. American Journal of Physiology 265(6 Part 2): R1399-R1403
Branham, W.S.; Fishman, R.; Streck, R.D.; Medlock, K.L.; De George, J.J.; Sheehan, D.M. 1996: ICi 182,780 inhibits endogenous estrogen-dependent rat uterine growth and tamoxifen-induced developmental toxicity. Biology of Reproduction 54(1): 160-167
Fabre, L.F.; Arvanitis, L.; Pultz, J.; Jones, V.M.; Malick, J.B.; Slotnick, V.B. 1995: ICI 204,636, a novel, atypical antipsychotic: Early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clinical Therapeutics 17(3): 366-378
Borison, R.L.; Arvanitis, L.A.; Miller, B.G. 1996: ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. Journal of Clinical Psychopharmacology 16(2): 158-169
Howe, B.B.; Keith, R.A.; Do, M.L.; Halterman, T.J.; Donahue, J.Y.; Schwartz, J.A.; Kau, S.T. 1993: ICI 206,970: a novel calcium channel blocker with eukalemic diuretic activity. Pharmacology 47(6): 369-377
Kau, S.; Johnston, P.; Li, J.; Zuzack, J.; Leszczynska, K.; Yochim, C.; Schwartz, J.; Giles, R. 1993: ICi 206,970: a novel eukalemic diuretic with calcium channel blocking activity. Methods and Findings in Experimental and Clinical Pharmacology 15(6): 357-369
Pressacco, J.; Hedley, D.W.; Erlichman, C. 1994: ICi D1694 and idoxuridine: a synergistic antitumor combination. Cancer Research 54(14): 3772-3778
Marshall, P.W.; Rouse, W.; Briggs, I.; Hargreaves, R.B.; Mills, S.D.; McLoughlin, B.J. 1993: ICi D7288, a novel sinoatrial node modulator. Journal of Cardiovascular Pharmacology 21(6): 902-906
Decraecke, H. 1996: ICIA5504, a new broad spectrum fungicide for cereals in Belgium. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 61(2A): 387-394
Osler, T.; Rutledge, R.; Deis, J.; Bedrick, E. 1996: ICISS: an international classification of disease-9 based injury severity score. Journal of Trauma 41(3): 380-6; Discussion 386-8
Morgalla, M.H.; Cuno, M.; Mettenleiter, H.; Will, B.E.; Krasznai, L.; Skalej, M.; Bitzer, M.; Grote, E.H. 1997: ICP Monitoring with a re-usable transducer: Experimental and clinical evaluation of the Gaeltec ICT/b pressure probe. Acta Neurochirurgica 139(6): 569-573
Nakagawa, J.; Tsuchiya, Y. 1995: ICP atomic emission spectrometry and ICP mass spectrometry. Japanese Journal of Toxicology and Environmental Health 41(2): 116-126
Sandri-Goldin, R.M. 1998: ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes and Development 12(6): 868-879
Brown, S.M.; MacLean, A.R.; Aitken, J.D.; Harland, J. 1994: ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro. Journal of General Virology 75: 3679-3686
Bolovan, C.A.; Sawtell, N.M.; Thompson, R.L. 1994: ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. Journal of Virology 68(1): 48-55
Smith, C.A.; Bates, P.; Rivera-Gonzalez, R.; Gu, B.; DeLuca, N.A. 1993: ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. Journal of Virology 67(8): 4676-4687
Zima, T.; Tesar, V.; Crkovská, J.; Stejskalová, A.; Pláteník, J.; Temínová, J.; Nemecek, K.; Janebová, M.; Stípek, S. 1998: ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 13(8): 1975-1979
Holm, B.; Jensen, P.B.; Sehested, M. 1996: ICRF-187 rescue in etoposide treatment in vivo. a model targeting high-dose topoisomerase Ii poisons to CNS tumors. Cancer ChemoTherapy and Pharmacology 38(3): 203-209
Tanimoto, C.; Hirakawa, S.; Kawasaki, H.; Hayakawa, N.; Ota, Z. 1995: ICRF-193 modifies etoposide-induced apoptosis in thymocytes. Acta Medica Okayama 49(6): 281-286
Iwai, M.; Hara, A.; Andoh, T.; Ishida, R. 1997: ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells. Febs Letters 406(3): 267-270
Takasuga, Y.; Andoh, T.; Yamashita, J.; Yagura, T. 1995: ICRF-193, an inhibitor of topoisomerase II, demonstrates that DNA replication in sperm nuclei reconstituted in Xenopus egg extracts does not require chromatin decondensation. Experimental Cell Research 217(2): 378-384
Lahtinen, T.; Tenhunen, M.; Väyrynen, M. 1993: ICRU reference points and maximum doses of rectum and bladder in intracavitary radiotherapy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 28(2): 174-176
Sele, B.; Cozzi, J.; Chevret, E.; Monteil, M.; Rousseaux, S.; Pelletier, R. 1996: ICSI and Klinefelter's syndrome. Contraception Fertilite Sexualite 24(7-8): 581-584
Salat-Baroux, J.; Mandelbaum, J.; Antoine, J.M.; Merviel, P.; Belaisch-Allart, J.; Boullu, S.; Cohen, J.; Junca, A.M.; Plachot, M. 1995: ICSI indications: Possible influence of oocyte quality on the results. Contraception Fertilite Sexualite 23(7-8): 481-483
Higgins, T.L.; Estafanous, F.G.; Loop, F.D.; Beck, G.J.; Lee, J.C.; Starr, N.J.; Knaus, W.A.; Cosgrove, D.M. 1997: ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Annals of Thoracic Surgery 64(4): 1050-1058
Norris, C.; Jacobs, P.; Rapoport, J.; Hamilton, S. 1995: ICU and non-ICU cost per day. Canadian Journal of Anaesthesia 42(3): 192-196
Brugger, S.; Sanchez, R.; Brugger, A., J.; Martinez, J.-Antonio 1998: ICV administration of CRF blocker (CRF9-41 Helical) reduces morphine withdrawal in rats. Progress in Neuro Psychopharmacology and Biological Psychiatry 22(5): 775-785
Hulsey, M.G.; Pless, C.M.; White, B.D.; Martin, R.J. 1995: ICV administration of anti-NPY antisense oligonucleotide: Effects on feeding behavior, body weight, peptide content and peptide release. Regulatory Peptides 59(2): 207-214
Hulsey, M.G.; Pless, C.M.; Martin, R.J. 1995: ICV administration of anti-corticotropin-releasing factor antisense oligonucleotide: Effects on feeding behavior and body weight. Regulatory Peptides 59(2): 241-246
Sun, M.; Martin, R.J.; Edwards, G.L. 1997: ICV beta-hydroxybutyrate: effects on food intake, body composition, and body weight in rats. Physiology and Behavior 61(3): 433-436
Van de Kar, L.D.; Alvarez Sanz, M.C.; Yracheta, J.M.; Kunimoto, K.; Li, Q.; Levy, A.D.; Rittenhouse, P.A. 1994: ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms. Pharmacology Biochemistry and Behavior 48(2): 429-436
Kemp, P.R.; Metcalfe, J.C.; Grainger, D.J. 1995: ID--a dominant negative regulator of skeletal muscle differentiation--is not involved in maturation or differentiation of vascular smooth muscle cells. Febs Letters 368(1): 81-86
Zhang, H.; Reynaud, S.; Kloc, M.; Etkin, L.D.; Spohr, G. 1995: Id gene activity during Xenopus embryogenesis. Mechanisms of Development 50(2-3): 119-130
Itoh, K. 1994: ID number recognition of X-ray films by a neural network. Computer Methods and Programs in Biomedicine 43(1-2): 15-18
Fleischhack, G.; Hasan, C.; Graf, N.; Mann, G.; Bode, U. 1998: IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: Experiences of a phase II trial. British Journal of Haematology 102(3): 647-655
Lorini, R.; d'Annunzio, G.; Vitali, L.; Scaramuzza, A. 1996: IDDM and autoimmune thyroid disease in the pediatric age group. Journal of Pediatric Endocrinology and Metabolism: Jpem 9(Suppl): 89-94
Stumbles, P.A.; Penhale, W.J. 1993: IDDM in rats induced by thymectomy and irradiation. Diabetes 42(4): 571-578
Blanz, B.J.; Rensch-Riemann, B.S.; Fritz-Sigmund, D.I.; Schmidt, M.H. 1993: IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care 16(12): 1579-1587
Kim, Y.J.; Zhou, Z.; Hurtado, J.; Wood, D.L.; Choi, A.S.; Pescovitz, M.D.; Warfel, K.A.; Vandagriff, J.; Davis, J.K.; Kwon, B.S. 1993: IDDM patients' sera recognize a novel 30-kD pancreatic autoantigen related to chymotrypsinogen. Immunological Investigations 22(3): 219-227
Undlien, D.E.; Hamaguchi, K.; Kimura, A.; Tuomilehto-Wolf, E.; Swai, A.B.; McLarty, D.G.; Tuomilehto, J.; Thorsby, E.; Rønningen, K.S. 1994: IDDM susceptibility associated with polymorphisms in the insulin gene region. A study of blacks, Caucasians and orientals. Diabetologia 37(8): 745-749
Boitard, C.; Larger, E.; Timsit, J.; Sempe, P.; Bach, J.F.; Boitard, C. 1994: IDDM: An islet or an immune disease?. Diabetologia 37(Suppl): S90-S98
Maloney, D.G.; Grillo-López, A.J.; Bodkin, D.J.; White, C.A.; Liles, T.M.; Royston, I.; Varns, C.; Rosenberg, J.; Levy, R. 1997: IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(10): 3266-3274
Jahnke, K.D. 1995: IDENTIFY-a menu-driven computer program compatible with MICRO-IS 5.0 for the probabilistic identification of bacteria. Journal of Microbiological Methods 21(2): 133-142
Sutherland, W.H.; Restieaux, N.J.; Nye, E.R.; Williams, M.J.; de Jong, S.A.; Robertson, M.C.; Walker, H.L. 1998: IDL composition and angiographically determined progression of atherosclerotic lesions during simvastatin therapy. Arteriosclerosis Thrombosis and Vascular Biology 18(4): 577-583
Klein, S.B.; Yeivin, A.; Becker, G.; Taylor, M.W. 1994: IDO mutants cross resistant to type I interferon retain p91-dependent gene induction. Journal of Interferon Research 14(6): 333-341
Henke, B.; Girzalsky, W.; Berteaux-Lecellier, V.; Erdmann, R. 1998: IDP3 encodes a peroxisomal NADP-dependent isocitrate dehydrogenase required for the beta-oxidation of unsaturated fatty acids. Journal of Biological Chemistry 273(6): 3702-3711
Rao, C.S.; Singh, P.P.; Junnarkar, A.Y.; Muralidhar, N.; Trivedi, B.S.; Rao, B.E. 1995: IDPH-8261--a new nonsteroidal antiinflammatory agent. Indian Journal of Experimental Biology 33(1): 28-33
Morbin, M.; Monaco, S.; Zanette, G.; Rizzuto, N. 1993: IDPN impairs post-traumatic regeneration of rat sciatic nerve. Neuropathology and Applied Neurobiology 19(6): 489-499
Birot, A.M.; Bouton, O.; Froissart, R.; Maire, I.; Bozon, D. 1996: IDS gene-pseudogene exchange responsible for an intragenic deletion in a hunter patient. Human Mutation 8(1): 44-50
Millat, G.; Froissart, R.; Maire, I.; Bozon, D. 1997: IDS transfer from overexpressing cells to IDS-deficient cells. Experimental Cell Research 230(2): 362-367
Miller, C.P.; McGehee, R.E.; Habener, J.F. 1994: IDX-1: a new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO Journal 13(5): 1145-1156
Strobel, S.; Bereswill, S.; Balig, P.; Allgaier, P.; Sonntag, H.G.; Kist, M. 1998: Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. Journal of Clinical Microbiology 36(5): 1285-1289
Biegalke, B.J. 1997: IE2 protein is insufficient for transcriptional repression of the human cytomegalovirus US3 promoter. Journal of Virology 71(10): 8056-8060
Aitchison, E.M. 1995: IEA Bioenergy Agreement Task XI: Municipal Solid Waste conversion to energy end of task review. Biomass and Bioenergy 9(1-5): 343-349
Walther, J.; Wilmanns, W.; Gerhartz, H.H. 1993: IEVM chemotherapy with rhGM-CSF support for aggressive non-Hodgkin's lymphomas: A pilot study. Annals of Hematology 66(3): 135-137
Wu, M.X.; Ao, Z.; Prasad, K.V.; Wu, R.; Schlossman, S.F. 1998: IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281(5379): 998-1001
Haggerty, T.J.; Lovett, S.T. 1997: IF3-mediated suppression of a GUA initiation codon mutation in the recJ gene of Escherichia coli. Journal of Bacteriology 179(21): 6705-6713
Skalli, O.; Jones, J.C.; Gagescu, R.; Goldman, R.D. 1994: IFAP 300 is common to desmosomes and hemidesmosomes and is a possible linker of intermediate filaments to these junctions. Journal of Cell Biology 125(1): 159-170
Maas, A.H. 1993: IFCC reference methods and materials for measurement of pH, gases and electrolytes in blood. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 214: 83-94
Dawson, M.J.; Trapani, J.A. 1995: IFi 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines. Journal of Cellular Biochemistry 57(1): 39-51
Volta, U.; Molinaro, N.; De Franceschi, L.; Fratangelo, D.; Bianchi, F.B. 1995: IFL- and ELISA-antigliadin antibodies recognize different antigenic reactivities from those of R1-antireticulin and antiendomysial antibodies. Italian Journal of Gastroenterology 27(2): 64-68
Weisz, A.; Kirchhoff, S.; Levi, B.Z. 1994: IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters. International Immunology 6(8): 1125-1131
Guldner, H.H.; Szostecki, C.; Grötzinger, T.; Will, H. 1992: IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. Journal of Immunology 149(12): 4067-4073
Routes, J.M. 1992: IFN increases class i MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. Journal of Immunology 149(7): 2372-2377
Ishikawa, R.; Biron, C.A. 1993: IFN induction and associated changes in splenic leukocyte distribution. Journal of Immunology 150(9): 3713-3727
Abrams, M.E.; Balish, M.J.; Brandt, C.R. 1995: IFN-alpha induces MxA gene expression in cultured human corneal fibroblasts. Experimental Eye Research 60(2): 137-142
Chakrabarti, D.; Hultgren, B.; Stewart, T.A. 1996: IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. Journal of Immunology 157(2): 522-528
Evans, S.S.; Collea, R.P.; Leasure, J.A.; Lee, D.B. 1993: IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. Journal of Immunology 150(3): 736-747
Nakajima, H.; Nakao, A.; Watanabe, Y.; Yoshida, S.; Iwamoto, I. 1994: IFN-alpha inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. Journal of Immunology 153(3): 1264-1270
Shenoy, M.; Baron, S.; Wu, B.; Goluszko, E.; Christadoss, P. 1995: IFN-alpha treatment suppresses the development of experimental autoimmune myasthenia gravis. Journal of Immunology 154(11): 6203-6208
Miller, H.; Bluth, M.H.; Chice, S.M.; Durkin, H.G.; Auci, D.L. 1996: IFN-alpha-mediated suppression of low-affinity FC(epsilon) receptors on Peyer's patch lymphocytes and augmentation of soluble CD23: implications for IgE responses. Journal of Leukocyte Biology 59(5): 725-727
Telasky, C.; Tredget, E.E.; Shen, Q.; Khorramizadeh, M.R.; Iwashina, T.; Scott, P.G.; Ghahary, A. 1998: IFN-alpha2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18(8): 571-577
Ishihara, H.; Kajiwara, K.; Ohshita, N.; Kimura, Y.; Nishizaki, T.; Ito, H. 1995: IFN-beta inhibition of etoposide resistance acquisition in vitro: studies using a human glioblastoma cell line. Anticancer Research 15(2): 283-287
Allavena, P.; Giardina, G.; Sen, S.; Colella, G.; Broggini, M.; D'Incalci, M. 1998: IFN-beta partially counteracts inhibition of natural killer activity induced by some antitumor agents. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18(2): 87-93
Testa, U.; Conti, L.; Sposi, N.M.; Varano, B.; Tritarelli, E.; Malorni, W.; Samoggia, P.; Rainaldi, G.; Peschle, C.; Belardelli, F. 1995: IFN-beta selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. Journal of Immunology 155(1): 427-435
Garvy, B.A.; Riley, R.L. 1994: IFN-gamma abrogates IL-7-dependent proliferation in pre-B cells, coinciding with onset of apoptosis. Immunology 81(3): 381-388
Thomas, H.E.; Parker, J.L.; Schreiber, R.D.; Kay, T.W. 1998: IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. Journal of Clinical Investigation 102(6): 1249-1257
Taha, R.A.; Kotsimbos, T.C.; Song, Y.L.; Menzies, D.; Hamid, Q. 1997: IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. American Journal of Respiratory and Critical Care Medicine 155(3): 1135-1139
Hendricks, R.L.; Tumpey, T.M.; Finnegan, A. 1992: IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. Journal of Immunology 149(9): 3023-3028
Paik, T.H.; Jo, E.G.; Park, J.H.; Park, J.K.; Kim, H.J. 1996: IFN-gamma and IL-4 mRNA expression of human peripheral blood mononuclear cells from PPD-reactive donor after in vitro stimulation with 30 kDa protein antigen of Mycobacterium tuberculosis. Journal of the Korean Society for Microbiology 31(2): 115-134
Noble, A.; Macary, P.A.; Kemeny, D.M. 1995: IFN-gamma and IL-4 regulate the growth and differentiation of CD8+ T cells into subpopulations with distinct cytokine profiles. Journal of Immunology 155(6): 2928-2937
Romer, L.H.; McLean, N.V.; Yan, H.C.; Daise, M.; Sun, J.; DeLisser, H.M. 1995: IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. Journal of Immunology 154(12): 6582-6592
Tannenbaum, C.S.; Major, J.A.; Hamilton, T.A. 1993: IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages. Journal of Immunology 151(12): 6833-6839
Shackelford, R.; Adams, D.O.; Johnson, S.P. 1995: IFN-gamma and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. Journal of Immunology 154(3): 1374-1382
Wang Guanhua, C.Q.; Zhu Meicai 1996: IFN-gamma cDNA genes expressed in stomach carcinoma cells and preliminary studies in tumor gene therapy. Zhonghua Weishengwuxue He Mianyixue Zazhi 16(6): 447-451
Gennari, R.; Alexander, J.W.; Eaves-Pyles, T. 1994: IFN-gamma decreases translocation and improves survival following transfusion and thermal injury. Journal of Surgical Research 56(6): 530-536
Sütas, Y.; Autio, S.; Rantala, I.; Isolauri, E. 1997: IFN-gamma enhances macromolecular transport across Peyer's patches in suckling rats: implications for natural immune responses to dietary antigens early in life. Journal of Pediatric Gastroenterology and Nutrition 24(2): 162-169
Rabinovitch, A.; Suarez-Pinzon, W.L.; Sorensen, O.; Bleackley, R.C.; Power, R.F. 1995: IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Journal of Immunology 154(9): 4874-4882
Traversari, C.; Meazza, R.; Coppolecchia, M.; Basso, S.; Verrecchia, A.; Van Der Bruggen, P.; Ardizzoni, A.; Gaggero, A.; Ferrini, S. 1997: IFN-gamma gene transfer restores HLA-class I expression and MAGE-3 antigen presentation to CTL in HLA-deficient small cell lung cancer. Gene Therapy 4(10): 1029-1035
Tsuji-Takayama, K.; Harashima, A.; Tahata, H.; Izumi, N.; Nishida, Y.; Namba, M.; Okuda, Y.; Ohta, T.; Kurimoto, M. 1996: IFN-gamma in combination with IL-3 accelerates platelet recovery in mice with 5-fluorouracil-induced marrow aplasia. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 16(6): 447-451
Bahia-Oliveira, L.M.; Gomes, J.A.; Rocha, M.O.; Moreira, M.C.; Lemos, E.M.; Luz, Z.M.; Pereira, M.E.; Coffman, R.L.; Dias, J.C.; Cançado, J.R.; Gazzinelli, G.; Corrêa-Oliveira, R. 1998: IFN-gamma in human Chagas' disease: protection or pathology?. Brazilian Journal of Medical and Biological Research 31(1): 127-131
Lafuse, W.P.; Brown, D.; Castle, L.; Zwilling, B.S. 1995: IFN-gamma increases cathepsin H mRNA levels in mouse macrophages. Journal of Leukocyte Biology 57(4): 663-669
Yoshida, A.; Koide, Y.; Uchijima, M.; Yoshida, T.O. 1994: IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochemical and Biophysical Research Communications 198(3): 857-861
Mattila, P.; Renkonen, R. 1992: IFN-gamma induces a phospholipase D dependent triphasic activation of protein kinase C in endothelial cells. Biochemical and Biophysical Research Communications 189(3): 1732-1738
Aas, V.; Larsen, K.; Iversen, J.G. 1998: IFN-gamma induces calcium transients and increases the capacitative calcium entry in human neutrophils. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18(3): 197-205
Xu, X.; Fu, X.Y.; Plate, J.; Chong, A.S. 1998: IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Research 58(13): 2832-2837
Tsuyuki, Y.; Fujimaki, H.; Hikawa, N.; Fujita, K.; Nagata, T.; Minami, M. 1998: IFN-gamma induces coordinate expression of MHC class I-mediated antigen presentation machinery molecules in adult mouse Schwann cells. Neuroreport 9(9): 2071-2075
Uciechowski, P.; Schwarz, M.; Gessner, J.E.; Schmidt, R.E.; Resch, K.; Radeke, H.H. 1998: IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. European Journal of Immunology 28(9): 2928-2935
Damore, M.A.; Omori, S.A.; Wall, R. 1996: IFN-gamma induces the kappa intron enhancer via an IFN-stimulated response element. Journal of Immunology 156(7): 2451-2457
Westermann, J.; Persin, S.; Matyas, J.; van der Meide, P.; Pabst, R. 1993: IFN-gamma influences the migration of thoracic duct B and T lymphocyte subsets in vivo. Random increase in disappearance from the blood and differential decrease in reappearance in the lymph. Journal of Immunology 150(9): 3843-3852
Conant, K.; Ahmed, U.; Schwartz, J.P.; Major, E.O. 1998: IFN-gamma inhibits AP-1 binding activity in human brain-derived cells through a nitric oxide dependent mechanism. Journal of Neuroimmunology 88(1-2): 39-44
Supriya, P.; Joshi, C.V.; Ajitkumar, P. 1998: IFN-gamma inhibits growth of WISH cells in a cell cycle phase-specific manner. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18(4): 215-217
Schindler, H.; Diefenbach, A.; Röllinghoff, M.; Bogdan, C. 1998: IFN-gamma inhibits the production of latent transforming growth factor-beta1 by mouse inflammatory macrophages. European Journal of Immunology 28(4): 1181-1188
Gregory, S.H.; Wing, E.J. 1993: IFN-gamma inhibits the replication of Listeria monocytogenes in hepatocytes. Journal of Immunology 151(3): 1401-1409
Kohler, J.; Heumann, D.; Garotta, G.; LeRoy, D.; Bailat, S.; Barras, C.; Baumgartner, J.D.; Glauser, M.P. 1993: IFN-gamma involvement in the severity of gram-negative infections in mice. Journal of Immunology 151(2): 916-921
Snapper, C.M.; Rosas, F.; Moorman, M.A.; Jin, L.; Shanebeck, K.; Klinman, D.M.; Kehry, M.R.; Mond, J.J.; Maliszewski, C.R. 1996: IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway. International Immunology 8(6): 877-885
Bhattacharya, S.; Manna, P.P.; Bandyopadhyay, S. 1993: IFN-gamma is directly cytostatic to the extracellular form (promastigote) of Leishmania donovani. Scandinavian Journal of Immunology 37(6): 680-683
Seelen, M.A.; Brooimans, R.A.; van der Woude, F.J.; van Es, L.A.; Daha, M.R. 1993: IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney International 44(1): 50-57
Colgan, S.P.; Morales, V.M.; Madara, J.L.; Polischuk, J.E.; Balk, S.P.; Blumberg, R.S. 1996: IFN-gamma modulates CD1d surface expression on intestinal epithelia. American Journal of Physiology 271(1 Pt 1): C276-C283
Adams, R.B.; Planchon, S.M.; Roche, J.K. 1993: IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. Journal of Immunology 150(6): 2356-2363
Gupta, S.; Pablo, A.M.; Jiang, X.c.; Wang, N.; Tall, A.R.; Schindler, C. 1997: IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. Journal of Clinical Investigation 99(11): 2752-2761
Donckier, V.; Abramowicz, D.; Bruyns, C.; Florquin, S.; Vanderhaeghen, M.L.; Amraoui, Z.; Dubois, C.; Vandenabeele, P.; Goldman, M. 1994: IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. Journal of Immunology 153(6): 2361-2368
Sweet, M.J.; Stacey, K.J.; Kakuda, D.K.; Markovich, D.; Hume, D.A. 1998: IFN-gamma primes macrophage responses to bacterial DNA. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 18(4): 263-271
Hayes, M.P.; Freeman, S.L.; Donnelly, R.P. 1995: IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine 7(5): 427-435
Leiby, D.A.; Schreiber, R.D.; Nacy, C.A. 1993: IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Microbial Pathogenesis 14(6): 495-500
Webber, S.; Zheng, R.; Kamal, A.; Withnall, M.; Karlsson, J.A. 1997: IFN-gamma production from human Th1 cells is controlled by Raf kinase. International Archives of Allergy and Immunology 113(1-3): 275-278
Sarzotti, M.; Gomes, M.da.P.; Hoffman, P.M. 1993: IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection. Viral Immunology 6(3): 207-217
Yi, A.K.; Chace, J.H.; Cowdery, J.S.; Krieg, A.M. 1996: IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. Journal of Immunology 156(2): 558-564
Kürschner, C.; Ozmen, L.; Garotta, G.; Dembic, Z. 1992: IFN-gamma receptor-Ig fusion proteins. Half-life, immunogenicity, and in vivo activity. Journal of Immunology 149(12): 4096-4100
Schijns, V.E.; Haagmans, B.L.; Rijke, E.O.; Huang, S.; Aguet, M.; Horzinek, M.C. 1994: IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. Journal of Immunology 153(5): 2029-2037
Xu, L.; Rothman, P. 1994: IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. International Immunology 6(4): 515-521
De Francesco, M.A.; Caruso, A.; Dima, F.; Cantalamessa, A.; Canaris, A.D.; Folghera, S.; Fiorentini, S.; Flamminio, G.; Licenziati, S.; Peroni, L.; Gao, J.; Garotta, G.; Turano, A. 1996: IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS. Scandinavian Journal of Immunology 43(1): 94-100
Ohmori, Y.; Hamilton, T.A. 1994: IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. Journal of Immunology 153(5): 2204-2212
Estes, D.M.; Closser, N.M.; Allen, G.K. 1994: IFN-gamma stimulates IgG2 production from bovine B cells costimulated with anti-mu and mitogen. Cellular Immunology 154(1): 287-295
Ferm, M.; Grönberg, A.; Tally, M. 1996: IFN-gamma treatment increases insulin binding and MHC class i expression in erythroleukemia cells. Immunological Investigations 25(1-2): 37-47
Watier, H.; Pancre, V.; Lando, D.; Capron, A.; Auriault, C. 1993: IFN-gamma treatment of rodents infected with erythrocytic stages of Plasmodium chabaudi: differential effects according to the immunological status. International Journal of Immunopharmacology 15(3): 293-299
Mitchell, T.J.; Naughton, M.; Norsworthy, P.; Davies, K.A.; Walport, M.J.; Morley, B.J. 1996: IFN-gamma up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. Journal of Immunology 156(11): 4429-4434
Ouellet, S.; Müller, E.; Rola-Pleszczynski, M. 1994: IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes. Journal of Immunology 152(10): 5092-5099
Burg, M.; Martin, U.; Rheinheimer, C.; Köhl, J.; Bautsch, W.; Böttger, E.C.; Klos, A. 1995: IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. Journal of Immunology 155(9): 4419-4426
Sekiya, M.; Adachi, M.; Takayama, S.; Reed, J.C.; Imai, K. 1997: IFN-gamma upregulates anti-apoptotic gene expression and inhibits apoptosis in IL-3-dependent hematopoietic cells. Biochemical and Biophysical Research Communications 239(2): 401-406
Porrini, A.M.; Reder, A.T. 1994: IFN-gamma, IFN-beta, and PGE1 affect monokine secretion: relevance to monocyte activation in multiple sclerosis. Cellular Immunology 157(2): 428-438
Fink, S.; de la Barrera, S.; Minnucci, F.; Valdez, R.; Baliña, L.M.; Sasiain, M.C. 1993: IFN-gamma, IL-6 and IL-4 modulate M. leprae- or PPD-specific cytotoxic T cells in leprosy patients. Scandinavian Journal of Immunology 38(6): 551-558
Carpenter, E.A.; Ruby, J.; Ramshaw, I.A. 1994: IFN-gamma, TNF, and IL-6 production by vaccinia virus immune spleen cells. An in vitro study. Journal of Immunology 152(6): 2652-2659
Yang, X.; HayGlass, K.T. 1993: IFN-gamma, but not IL-4, synthesis by antigen-primed murine T cells is IL-2 dependent. Differential requirements in de novo and established responses. Journal of Immunology 150(10): 4354-4363
Ariizumi, K.; Meng, Y.; Bergstresser, P.R.; Takashima, A. 1995: IFN-gamma-dependent IL-7 gene regulation in keratinocytes. Journal of Immunology 154(11): 6031-6039
König, A.; Happle, R.; Hoffmann, R. 1997: IFN-gamma-induced HLA-DR but not ICAM-1 expression on cultured dermal papilla cells is downregulated by TNF-alpha. Archives of Dermatological Research 289(8): 466-470
Lian, R.H.; Kotwal, G.J.; Wellhausen, S.R.; Hunt, L.A.; Justus, D.E. 1996: IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. Journal of Immunology 157(2): 864-873
Franková, D.; Zidek, Z. 1998: IFN-gamma-induced TNF-alpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-gamma. European Journal of Immunology 28(3): 838-843
Nagano, C.; Wakebe, H.; Azuma, A.; Imagawa, K.; Kikuchi, M. 1998: IFN-gamma-induced iNOS mRNA expression is inhibited by rebamipide in murine macrophage RAW264.7 cells. Digestive Diseases and Sciences 43(9 Suppl): 118s-124s
Thomas, S.M.; Garrity, L.F.; Brandt, C.R.; Schobert, C.S.; Feng, G.S.; Taylor, M.W.; Carlin, J.M.; Byrne, G.I. 1993: IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. Journal of Immunology 150(12): 5529-5534
Sakurai, S.; Kamachi, K.; Konda, T.; Komuro, K.; Uchida, T. 1997: IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice. Japanese Journal of Medical Science and Biology 50(1): 35-43
Romieu, R.; Baratin, M.; Kayibanda, M.; Guillet, J.G.; Viguier, M. 1998: IFN-gamma-secreting Th cells regulate both the frequency and avidity of epitope-specific CD8+ T lymphocytes induced by peptide immunization: an ex vivo analysis. International Immunology 10(9): 1273-1279
Love, K.S.; Lakshmanan, R.R.; Butterfield, J.H.; Fox, C.C. 1996: IFN-gamma-stimulated enhancement of MHC class II antigen expression by the human mast cell line HMC-1. Cellular Immunology 170(1): 85-90
Imanishi, K.; Akatsuka, H.; Inada, K.; Uchiyama, T. 1995: IFN-gamma-stimulated human vascular endothelial cells function as accessory cells for superantigen-induced TNF production in human T cells. International Archives of Allergy and Immunology 106(2): 163-165
Baccarini, M.; Dello Sbarba, P.; Buscher, D.; Bartocci, A.; Stanley, E.R. 1992: IFN-gamma/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor. Journal of Immunology 149(8): 2656-2661
Hernandez, J.; Carrasco, J.; Arbones, M.L.; Hidalgo, J. 1997: IFN-gammaR-/- mice show an enhanced liver and brain metallothionein I + II response to endotoxin but not to immobilization stress. Journal of Endotoxin Research 4(5): 363-370
Asselin, E.; Lacroix, D.; Fortier, M.A. 1997: IFN-tau increases PGE2 production and COX-2 gene expression in the bovine endometrium in vitro. Molecular and Cellular Endocrinology 132(1-2): 117-126
Mujtaba, M.G.; Streit, W.J.; Johnson, H.M. 1998: IFN-tau suppresses both the autoreactive humoral and cellular immune responses and induces stable remission in mice with chronic experimental allergic encephalomyelitis. Cellular Immunology 186(2): 94-102
Hobeika, A.C.; Etienne, W.; Cruz, P.E.; Subramaniam, P.S.; Johnson, H.M. 1998: IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential. International Journal of Cancer 77(1): 138-145
Wang, X.; Johansen, L.M.; Tae, H.J.; Taparowsky, E.J. 1996: IFP 35 forms complexes with B-ATF, a member of the AP1 family of transcription factors. Biochemical and Biophysical Research Communications 229(1): 316-322
Bange, F.C.; Vogel, U.; Flohr, T.; Kiekenbeck, M.; Denecke, B.; Böttger, E.C. 1994: IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. Journal of Biological Chemistry 269(2): 1091-1098
Green, N.S.; Verdugo, G.; Getman, M.E.; Scharft, M.D. 1997: IG V region hypermutation in B cell hybrids mimics in vivo mutation and allows for isolation of clonal variants. Molecular Immunology 34(15): 1095-1103,.
Lindh, J.; Nordenson, I.; Osterman, B.; Rudolphi, O.; Roos, G. 1993: Ig-gene and T-cell receptor gene rearrangements in a secondary, mono-histiocytic malignancy. Acta Oncologica 32(5): 525-530
Aijala, M.; Huuskonen, E. 1993: IGCC demonstration plant for peat. Bioresource Technology 46(1-2): 119-123
Holopainen, O. 1993: IGCC plant employing heavy-petroleum residues. Bioresource Technology 46(1-2): 125-128
Stahl, K.; Neergaard, M. 1998: IGCC power plant for biomass utilisation, Varnamo, Sweden. Biomass and Bioenergy 15(3): 205-211
Hise, M.K.; Mantzouris, N.M.; Lahn, J.S.; Sheikh, M.S.; Shao, Z.M.; Fontana, J.A. 1994: IGF binding protein 5 and IGF-I receptor regulation in hypophysectomized rat kidneys. American Journal of Physiology 266(1 Pt 2): F147-F154
Ewton, D.Z.; Florini, J.R. 1995: IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. Journal of Endocrinology 144(3): 539-553
Liu, J.; Chamberlain, C.G.; McAvoy, J.W. 1996: IGF enhancement of FGF-induced fibre differentiation and DNA synthesis in lens explants. Experimental Eye Research 63(6): 621-629
Fletcher, T.P.; Thomas, G.B.; Dunshea, F.R.; Moore, L.G.; Clarke, I.J. 1995: IGF feedback effects on growth hormone secretion in ewes: evidence for action at the pituitary but not the hypothalamic level. Journal of Endocrinology 144(2): 323-331
Martin, D.M.; Singleton, J.R.; Meghani, M.A.; Feldman, E.L. 1993: IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regulatory Peptides 48(1-2): 225-232
Lee, A.V.; Hilsenbeck, S.G.; Yee, D. 1998: IGF system components as prognostic markers in breast cancer. Breast Cancer Research and Treatment 47(3): 295-302
Grizard, G. 1994: IGF(s) and testicular functions: Production and effects of IGF-I on Leydig cells. Contraception Fertilite Sexualite 22(9): 551-555
van Neck, J.W.; Flyvbjerg, A.; Schuller, A.G.; Rosato, R.R.; Groffen, C.; van Kleffens, M.; Lindenbergh-Kortleve, D.; Dørup, I.; Drop, S.L. 1997: IGF, type I IGF receptor and IGF-binding protein mRNA expression in kidney and liver of potassium-depleted and normal rats infused with IGF-I. Journal of Molecular Endocrinology 19(1): 59-66
Schuller, A.G.; van Neck, J.W.; Beukenholdt, R.W.; Zwarthoff, E.C.; Drop, S.L. 1995: IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung. Journal of Molecular Endocrinology 14(3): 349-355
Rasat, R.; Livesey, J.L.; Espiner, E.A.; Abbott, G.D.; Donald, R.A. 1996: IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion. New Zealand Medical Journal 109(1021): 156-159
Richardson, N.A.; Chamberlain, C.G.; McAvoy, J.W. 1993: IGF-1 enhancement of FGF-induced lens fiber differentiation in rats of different ages. IOVS Investigative Ophthalmology and Visual Science 34(12): 3303-3312
Giacobini, M.M.; Zetterström, R.H.; Young, D.; Hoffer, B.; Sara, V.; Olson, L. 1995: IGF-1 influences olfactory bulb maturation. Evidence from anti-IGF-1 antibody treatment of developing grafts in oculo. Brain Research. Developmental Brain Research 84(1): 67-76
Yoshitake, S.; Kitano, T.; Hattori, S.; Yamamoto, H.; Mizutani, A.; Noguchi, T.; Oda, S.; Taniguchi, K. 1996: IGF-1 levels in elderly patients during perioperative period. Masui. Japanese Journal of Anesthesiology 45(11): 1330-1334
Blair, L.A.; Marshall, J. 1997: IGF-1 modulates N and L calcium channels in a PI 3-kinase-dependent manner. Neuron 19(2): 421-429
Tsao, T.; Hsu, F.W.; Rabkin, R. 1997: IGF-I receptor binding, autophosphorylation, and kinase activity in kidney and muscle of acutely uremic rats. American Journal of Physiology 272(3 Pt 2): F325-F332
Sell, C.; Ptasznik, A.; Chang, C.D.; Swantek, J.; Cristofalo, V.J.; Baserga, R. 1993: IGF-1 receptor levels and the proliferation of young and senescent human fibroblasts. Biochemical and Biophysical Research Communications 194(1): 259-265
Jendraschak, E.; Kaminski, W.E.; Kiefl, R.; von Schacky, C. 1998: IGF-1, PDGF and CD18 are adherence-responsive genes: Regulation during monocyte differentiation. Biochimica et Biophysica Acta 1396(3): 320-335
Lamonerie, T.; Lavialle, C.; Haddada, H.; Brison, O. 1995: IGF-2 autocrine stimulation in tumorigenic clones of a human colon-carcinoma cell line. International Journal of Cancer 61(4): 587-592
Harvey, M.B.; Kaye, P.L. 1992: IGF-2 stimulates growth and metabolism of early mouse embryos. Mechanisms of Development 38(3): 169-173
Reinecke, M.; Weimar, E.; Maake, C.; Drakenberg, K.; Falkmer, S.; Sara, V.R. 1994: IGF-2-like peptides are present in insulin cells of the elasmobranchian endocrine pancreas: An immunohistochemical and chromatographic study. Histochemistry 102(5): 365-371
Drivdahl, R.H.; Loop, S.M.; Andress, D.L.; Ostenson, R.C. 1995: IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3. Prostate 26(2): 72-79
Wilson, M.E. 1995: IGF-I administration advances the decrease in hypersensitivity to oestradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. Journal of Endocrinology 145(1): 121-130
Hinton, P.S.; Peterson, C.A.; Dahly, E.M.; Ney, D.M. 1998: IGF-i alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment. American Journal of Physiology 274(4): R912-R920
Gaetje, R. 1994: IGF-i and EGF influence on steroid secretion and morphology of human granulosa cells of IVF-cycles and natural cycles in vitro. Clinical and Experimental Obstetrics and Gynecology 21(1): 14-23
Santucci, D.; Cagiano, R.; Calamandrei, G. 1994: IGF-I and IGF-I24-41 but not IGF-I57-70 affect somatic and neurobehavioral development of newborn male mice. Brain Research Bulletin 35(4): 367-371
Lacroix, M.C.; Servely, J.L.; Kann, G. 1995: IGF-I and IGF-II receptors in the sheep placenta: evolution during the course of pregnancy. Journal of Endocrinology 144(1): 179-191
Nogami, H.; Watanabe, T.; Kobayashi, S. 1994: IGF-I and IGF-binding protein gene expressions in spontaneous dwarf rat. American Journal of Physiology 267(3 Pt 1): E396-E401
Cianfarani, S.; Germani, D.; Rossi, L.; Argirò, G.; Boemi, S.; Lemon, M.; Holly, J.M.; Branca, F. 1998: IGF-I and IGF-binding protein-1 are related to cortisol in human cord blood. European Journal of Endocrinology 138(5): 524-529
Butler, A.A.; Gallaher, B.W.; Ambler, G.R.; Gluckman, P.D.; Breier, B.H. 1996: IGF-i and IGF-binding protein-3 in plasma of GH-deficient rats. Journal of Endocrinology 150(1): 67-76
Eppenberger-Eberhardt, M.; Aigner, S.; Donath, M.Y.; Kurer, V.; Walther, P.; Zuppinger, C.; Schaub, M.C.; Eppenberger, H.M. 1997: IGF-I and bFGF differentially influence atrial natriuretic factor and alpha-smooth muscle actin expression in cultured atrial compared to ventricular adult rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 29(8): 2027-2039
Dunger, D.B.; Acerini, C.L. 1998: IGF-i and diabetes in adolescence. Diabetes and Metabolism 24(2): 101-107
Guan, Z.; Buckman, S.Y.; Baier, L.D.; Morrison, A.R. 1998: IGF-I and insulin amplify IL-1beta-induced nitric acid and prostaglandin biosynthesis. American Journal of Physiology 274(4 Part 2): F673-F679
Dealy, C.N.; Kosher, R.A. 1996: IGF-i and insulin in the acquisition of limb-forming ability by the embryonic lateral plate. Developmental Biology 177(1): 291-299
Boge, A.; Sauerwein, H.; Meyer, H.H. 1995: IGF-i and insulin receptors in bovine skeletal muscle: comparisons of different developmental ages, two different genotypes and various individual muscles. Experimental and Clinical Endocrinology and Diabetes: Official Journal German Society of Endocrinology and German Diabetes Association 103(2): 99-104
Sanaka, T.; Shinobe, M.; Ando, M.; Hizuka, N.; Kawaguchi, H.; Nihei, H. 1994: IGF-I as an early indicator of malnutrition in patients with end-stage renal disease. Nephron 67(1): 73-81
Bohé, J.; Ding, H.; Qing, D.P.; Yoon, K.; Hirschberg, R.; Wolfgang, G.H.; Kopple, J.D. 1998: IGF-i binding proteins, IGF-i binding protein mRNA and IGF-i receptor mRNA in rats with acute renal failure given IGF-i. Kidney International 54(4): 1070-1082
Geffner, M.E.; Bersch, N.; Scott, M.; Bailey, R.C.; Golde, D.W. 1996: IGF-I does not mediate T-lymphoblast colony formation in response to estradiol, testosterone, 1,25(OH)2 vitamin D3, and triiodothyronine: studies in control and pygmy T-cell lines. Biochemical and Molecular Medicine 59(1): 72-79
Akahori, Y.; Horie, H. 1997: IGF-I enhances neurite regeneration but is not required for its survival in adult DRG explant. Neuroreport 8(9-10): 2265-2269
Barale, E.; Torre, M.; Haimann, C.; Lovisolo, D. 1998: IGF-I enhances survival of embryonic chick ciliary ganglion neurons in a calcium-dependent way. Neuroreport 9(11): 2513-2517
Hill, D.J.; Sedran, R.J.; Brenner, S.L.; McDonald, T.J. 1997: IGF-i has a dual effect on insulin release from isolated, perifused adult rat islets of Langerhans. Journal of Endocrinology 153(1): 15-25
Loffing-Cueni, D.; Schmid, A.C.; Graf, H.; Reinecke, M. 1998: IGF-I in the bony fish Cottus scorpius: cDNA, expression and differential localization in brain and islets. Molecular and Cellular Endocrinology 141(1-2): 187-194
Reape, T.J.; Kanczler, J.M.; Ward, J.P.; Thomas, C.R. 1996: IGF-i increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells. American Journal of Physiology 270(4 Part 2): H1141-H1148
Pendergrass, M.; Fazioni, E.; Collins, D.; DeFronzo, R.A. 1998: IGF-I increases forearm blood flow without increasing forearm glucose uptake. American Journal of Physiology 275(2): E345-E350
Zimmermann, E.M.; Li, L.; Hou, Y.T.; Cannon, M.; Christman, G.M.; Bitar, K.N. 1997: IGF-i induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. American Journal of Physiology 273(4): G875-G882
Weimann, E.; Helmers, G. 1997: IGF-I influences erythropoietin levels during states of hyperinsulinism in diabetic neonates. Acta Medica Auxologica 29(1): 29-33
Pørksen, N.; Hussain, M.A.; Bianda, T.L.; Nyholm, B.; Christiansen, J.S.; Butler, P.C.; Veldhuis, J.D.; Froesch, E.R.; Schmitz, O. 1997: IGF-i inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-i infusion rates. American Journal of Physiology 272(3 Part 1): E352-E358
Lorenzo, M.; Valverde, A.M.; Teruel, T.; Benito, M. 1993: IGF-I is a mitogen involved in differentiation-related gene expression in fetal rat brown adipocytes. Journal of Cell Biology 123(6 Pt 1): 1567-1575
Maccario, M.; Grottoli, S.; Aimaretti, G.; Gianotti, L.; Endrio Oleandri, S.; Procopio, M.; Savio, P.; Tassone, F.; Ramunni, J.; Camanni, F.; Ghigo, E. 1998: IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. Panminerva Medica 40(2): 98-102
Sugimoto, T.; Kanatani, M.; Kano, J.; Kobayashi, T.; Yamaguchi, T.; Fukase, M.; Chihara, K. 1994: IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation. American Journal of Physiology 266(5 Pt 1): E709-E716
Lee, H.C.; Lee, K.W.; Chung, C.H.; Chung, Y.S.; Lee, E.J.; Lim, S.K.; Kim, K.R.; Huh, K.B.; Lee, S.C.; Kwon, O.W. 1994: IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy. Diabetes Research and Clinical Practice 24(2): 85-88
Kooijman, R.; Rijkers, G.T.; Zegers, B.J. 1996: IGF-I potentiates interleukin-2 production in human peripheral T cells. Journal of Endocrinology 149(2): 351-356
Dews, M.; Nishimoto, I.; Baserga, R. 1997: IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Receptors and Signal Transduction 7(4): 231-240
Guo, W.; Kada, K.; Kamiya, K.; Toyama, J. 1997: IGF-I regulates K(+)-channel expression of cultured neonatal rat ventricular myocytes. American Journal of Physiology 272(6 Pt 2): H2599-H2606
Standley, P.R.; Zhang, F.; Zayas, R.M.; Muniyappa, R.; Walsh, M.F.; Cragoe, E.; Sowers, J.R. 1997: IGF-i regulation of Na(+)-K(+)-ATPase in rat arterial smooth muscle. American Journal of Physiology 273(1 Part 1): E113-E121
Cortez, A.B.; Van Dop, C.; Bailey, R.C.; Bersch, N.; Scott, M.; Golde, D.W.; Geffner, M.E. 1996: IGF-I resistance in virus-transformed B-lymphocytes from African Efe Pygmies. Biochemical and Molecular Medicine 58(1): 31-36
Adashi, E.Y.; Resnick, C.E.; Rosenfeld, R.G. 1994: IGF-I stimulates granulosa cell-derived insulin-like growth factor binding protein-5: Evidence for medication via type I IGF receptors. Molecular and Cellular Endocrinology 99(2): 279-284
Kuemmerle, J.F.; Bushman, T.L. 1998: IGF-i stimulates intestinal muscle cell growth by activating distinct Pi 3-kinase and MAP kinase pathways. American Journal of Physiology 275(1): G151-G158
Hobler, S.C.; Williams, A.B.; Fischer, J.E.; Hasselgren, P.O. 1998: IGF-i stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats. American Journal of Physiology 274(2): R571-R576
McKillop, I.; Haylor, J.; el Nahas, A.M. 1995: IGF-I stimulates renal function in the isolated rat kidney: inhibition by aminoguanidine and nitroarginine methyl ester. Experimental Nephrology 3(1): 49-57
Jacob, R.; Hu, X.; Niederstock, D.; Hasan, S.; McNulty, P.H.; Sherwin, R.S.; Young, L.H. 1996: IGF-i stimulation of muscle protein synthesis in the awake rat: permissive role of insulin and amino acids. American Journal of Physiology 270(1 Part 1): E60-E66
Laron, Z.; Klinger, B. 1994: IGF-I treatment of adult patients with Laron syndrome: Preliminary results. Clinical Endocrinology 41(5): 631-638
Klauwer, D.; Blum, W.F.; Hanitsch, S.; Rascher, W.; Lee, P.D.; Kiess, W. 1997: IGF-I, IGF-II, free IGF-I and IGFBP-1, -2 and -3 levels in venous cord blood: Relationship to birthweight, length and gestational age in healthy newborns. Acta Paediatrica 86(8): 826-833
Roy, R.R.; Tri, C.; Grossman, E.J.; Talmadge, R.J.; Grindeland, R.E.; Mukku, V.R.; Edgerton, V.R.; Grindeland, R.E. 1996: IGF-I, growth hormone, and/or exercise effects on non-weight-bearing soleus of hypophysectomized rats. Journal of Applied Physiology 81(1): 302-311
Dealy, C.N.; Kosher, R.A. 1996: IGF-I, insulin and FGFs induce outgrowth of the limb buds of amelic mutant chick embryos. Development 122(4): 1323-1330
Ramagnolo, D.; Akers, R.M.; Byatt, J.C.; Wong, E.A.; Turner, J.D. 1994: IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells. Molecular and Cellular Endocrinology 102(1-2): 131-139
Shinobe, M.; Sanaka, T.; Nihei, H.; Sugino, N. 1997: IGF-I/IGFBP-1 as an index for discrimination between responder and nonresponder to recombinant human growth hormone in malnourished uremic patients on hemodialysis. Nephron 77(1): 29-36
Benito, M.; Valverde, A.M.; Lorenzo, M. 1996: IGF-I: A mitogen also involved in differentiation processes in mammalian cells. International Journal of Biochemistry and Cell Biology 28(5): 499-510
Nason, K.S.; Binder, N.D.; Labarta, J.I.; Rosenfeld, R.G.; Gargosky, S.E. 1996: IGF-Ii and IGF-binding proteins increase dramatically during rabbit pregnancy. Journal of Endocrinology 148(1): 121-130
Zumkeller, W.; Mahmood, A.; Dellow, R.; Schofield, P.N. 1995: IGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood. Clinical Molecular Pathology 48(6): M333-M341
Ewton, D.Z.; Roof, S.L.; Magri, K.A.; McWade, F.J.; Florini, J.R. 1994: IGF-Ii is more active than IGF-i in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-i delay differentiation. Journal of Cellular Physiology 161(2): 277-284
Giani, C.; Cullen, K.J.; Campani, D.; Rasmussen, A. 1996: IGF-Ii mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study. Breast Cancer Research and Treatment 41(1): 43-50
Melino, G.; Stephanou, A.; Annicchiarico-Petruzzelli, M.; Finazzi-Agró, A.; Knight, R.A.; Lightman, S.L. 1992: IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth. Neuroscience Letters 144(1-2): 25-28
Fitzsimmons, R.J.; Ryaby, J.T.; Magee, F.P.; Baylink, D.J. 1995: IGF-Ii receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 10(5): 812-819
Jacobsen, C.; Jessen, H.; Flyvbjerg, A. 1995: IGF-II receptors in luminal and basolateral membranes isolated from pars convoluta and pars recta of rabbit proximal tubule. Biochimica Et Biophysica Acta 1235(1): 85-92
Katz, L.E.; Bhala, A.; Camron, E.; Nunn, S.E.; Hintz, R.L.; Cohen, P. 1997: IGF-II, IGF-binding proteins and IGF receptors in pancreatic beta-cell lines. Journal of Endocrinology 152(3): 455-464
Han, V.K.; Matsell, D.G.; Delhanty, P.J.; Hill, D.J.; Shimasaki, S.; Nygard, K. 1996: IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Hormone Research 45(3-5): 160-166
Chen, Y.; Gustafsson, B.; Arnqvist, H.J. 1997: IGF-binding protein-2 is induced during development of urinary bladder hypertrophy in the diabetic rat. American Journal of Physiology 272(2 Part 1): E297-E303
Babajko, S.; Leneuve, P.; Loret, C.; Binoux, M. 1997: IGF-binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells: its production is both IGF- and cell density-dependent. Journal of Endocrinology 152(2): 221-227
Leighton, J.K.; Grimes, R.W.; Canning, S.F.; Hammond, J.M. 1994: IGF-binding proteins are differentially regulated in an ovarian granulosa cell line. Molecular and Cellular Endocrinology 106(1-2): 75-80
Oh, Y. 1998: IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Research and Treatment 47(3): 283-293
Martel-Pelletier, J.; Di Battista, J.A.; Lajeunesse, D.; Pelletier, J.P. 1998: IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflammation Research: Official Journal of the European Histamine Research Society . 47(3): 90-100
Uyeno, S.; Aoki, Y.; Nata, M.; Sagisaka, K.; Kayama, T.; Yoshimoto, T.; Ono, T. 1996: IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Research 56(23): 5356-5359
Hedborg, F.; Ohlsson, R.; Sandstedt, B.; Grimelius, L.; Hoehner, J.C.; Pählman, S. 1995: IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. American Journal of Pathology 146(4): 833-847
Hills, F.A.; Gunn, L.K.; Hardiman, P.; Thamaratnam, S.; Chard, T. 1996: IGFBP-1 in the placenta, membranes and fetal circulation: Levels at term and preterm delivery. Early Human Development 44(1): 71-76
Jenkins, P.J.; Ibanez-Santos, X.; Holly, J.; Cotterill, A.; Perry, L.; Wolman, R.; Harries, M.; Grossman, A. 1993: IGFBP-1: a metabolic signal associated with exercise-induced amenorrhoea. Neuroendocrinology 57(4): 600-604
Menouny, M.; Binoux, M.; Babajko, S. 1998: IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. International Journal of Cancer 77(6): 874-879
Booth, B.A.; Boes, M.; Andress, D.L.; Dake, B.L.; Kiefer, M.C.; Maack, C.; Linhardt, R.J.; Bar, K.; Caldwell, E.E.; Weiler, J. 1995: IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regulation 5(1): 1-17
Shao Zhimin, J.M.; Shen Zhenzhou 1996: IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma cell lines and patients specimens. Acta Academiae Medicinae Shanghai 23(6): 403-407
de Herder, W.W.; van der Lely, A.J.; Janssen, J.A.; Uitterlinden, P.; Hofland, L.J.; Lamberts, S.W. 1995: IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clinical Endocrinology 43(4): 501-505
Booth, B.A.; Boes, M.; Bar, R.S. 1996: IGFBP-3 proteolysis by plasmin, thrombin, serum: heparin binding, IGF binding, and structure of fragments. American Journal of Physiology 271(3 Pt 1): E465-E470
Gelato, M.C.; Frost, R.A. 1997: IGFBP-3. Functional and structural implications in aging and wasting syndromes. Endocrine 7(1): 81-85
Oh, Y. 1997: IGFBPs and neoplastic models. new concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine 7(1): 111-113
Gourmelen, M.; Perin, L.; Le Bouc, Y. 1994: IGFs and their binding proteins. Nuclear Medicine and Biology 21(3): 297-302
Robinson, D.; Shibuya, K.; Mui, A.; Zonin, F.; Murphy, E.; Sana, T.; Hartley, S.B.; Menon, S.; Kastelein, R.; Bazan, F.; O'Garra, A. 1997: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7(4): 571-581
Daily, J.; Werner, B.; Soiffer, R.; Fingeroth, J. 1998: IGIV: A potential role for hepatitis B prophylaxis in the bone marrow pertransplant period. Bone Marrow Transplantation 21(7): 739-742
Chalmers, R.; Guhathakurta, A.; Benjamin, H.; Kleckner, N. 1998: IHF modulation of Tn10 transposition: Sensory transduction of supercoiling status via a proposed protein/DNA molecular spring. Cell 93(5): 897-908
Goshima, N.; Kano, Y.; Tanaka, H.; Kohno, K.; Iwaki, T.; Imamoto, F. 1994: IHF supresses the inhibitory effect of H-NS on HU function in the hin inversion system. Gene 141(1): 17-23
Black, L.K.; Maier, R.J. 1995: IHF- and RpoN-dependent regulation of hydrogenase expression in Bradyrhizobium japonicum. Molecular Microbiology 16(3): 405-413
Browdy, C., L.; Holloway, J., D.,. Jr.;; King, C., O.; Stokes, A., D.; Hopkins, J.S.; Sandifer, P., A. 1993: IHHN virus and intensive culture of Penaeus vannamei: Effects of stocking density and water exchange rates. Journal of Crustacean Biology 13(1): 87-94
Wöber-Bingöl, C.; Wöber, C.; Wagner-Ennsgraber, C.; Zebenholzer, K.; Vesely, C.; Geldner, J.; Karwautz, A. 1996: IHS criteria and gender: A study on migraine and tension-type headache in children and adolescents. Cephalalgia: An International Journal of Headache 16(2): 107-112
Wöber-Bingöl, C.; Wöber, C.; Wagner-Ennsgraber, C.; Karwautz, A.; Vesely, C.; Zebenhoizer, K.; Geldner, J. 1996: IHS criteria for migraine and tension-type headache in children and adolescents. Headache 36(4): 231-238
Betterle, C.; Volpato, M.; Rees Smith, B.; Furmaniak, J.; Chen, S.; Zanchetta, R.; Greggio, N.A.; Pedini, B.; Boscaro, M.; Presotto, F. 1997: II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. Journal of Clinical Endocrinology and Metabolism 82(3): 939-942
Badawy, I., H.; Mekkawy, A., A.; Hegazi, S.M. 1992: II. Bioavailability of iron of enriched bread diets with iron and amino acids. Egyptian Journal of Food Science 20(2): 211-220
Ishay, J., S.; Barenholz-Paniry, V.; Bitler, A. 1997: II. Electric energy transfer in hornet silk caps: A qualitative approach to the dynamics of charge release. Physiological Chemistry and Physics and Medical NMR 29(2): 231-241
Nonaka, K.; Sasaki, Y.; Yanagita, K.; Matsumoto, T.; Watanabe, Y.; Nakata, M. 1993: Intrauterine effect of dam on prenatal development of craniofacial complex of mouse embryo. Journal of Craniofacial Genetics and Developmental Biology 13(3): 206-212
Van-Loey, A.M.; Haentjens, T.H.; Smout, C.; Hendrickx, M.E.; Tobback, P.P. 1997: II. The use of an enzymic time temperature integrator to monitor lethal efficacy of sterilization of low-acid canned foods. Food Biotechnology (New York) 11(2): 169-188
Detterbeck, F.C.; Socinski, M.A. 1997: IIB or not IIB: the current question in staging non-small cell lung cancer. Chest 112(1): 229-234
Park, T.J. 1998: IID sensitivity differs between two principal centers in the interaural intensity difference pathway: the LSO and the IC. Journal of Neurophysiology 79(5): 2416-2431
Decoursey, T.E.; Kim, S.Y.; Silver, M.R.; Quandt, F.N. 1996: Ion channel expression in PMA-differentiated human THP-1 macrophages. Journal of Membrane Biology 152(2): 141-157
Jackson, T.J. 1993: III. Measuring surface soil moisture using passive microwave remote sensing. Hydrological Processes 7(2): 139-152
Jacobs-El, J.; Ashley, W.; Russell, B. 1993: IIx and slow myosin expression follow mitochondrial increases in transforming muscle fibers. American Journal of Physiology 265(1 Part 1): C79-C84
Mercurio, F.; Zhu, H.; Murray, B.W.; Shevchenko, A.; Bennett, B.L.; Li, J.; Young, D.B.; Barbosa, M.; Mann, M.; Manning, A.; Rao, A. 1997: IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278(5339): 860-866
Kondo, Y.; Oka, H.; Abe, A.; Tanabe, A. 1994: IL 2 activity and dialysable suppressive factor in chicken lymphocyte culture medium. Japanese Poultry Science 31(4): 254-261
Appasamy, P.M. 1992: IL 7-induced T cell receptor-gamma gene expression by pre-T cells in murine fetal liver cultures. Journal of Immunology 149(5): 1649-1656
Zumbihl, R.; Dornand, J.; Fischer, T.; Cabane, S.; Rappuoli, R.; Bouaboula, M.; Casellas, P.; Rouot, B. 1995: IL-1 stimulates a diverging signaling pathway in EL4 6.1 thymoma cells. IL-2 release, but not IL-2 receptor expression, is sensitive to pertussis toxin. Journal of Immunology 155(1): 181-189
Abo, E.H.uda, M.M.; Shousha, S.A.o 1997: IL-1 activity in human fascioliasis before and after treatment with bithionol and dehydroemetine. Journal of the Medical Research Institute 18(1): 74-82
Santavenere, E.; Di Pietro, R.; Centurione, M.A.; Trubiani, O.; Zamai, L.; Rana, R. 1994: IL-1 alpha antiproliferative and differentiative effects on Daudi lymphoma cells: multiparametric analysis. Cell Biology International 18(8): 777-782
Hammerberg, C.; Bata-Csorgo, Z.; Voorhees, J.J.; Cooper, K.D. 1998: IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis. Archives of Dermatological Research 290(7): 367-374
Apte, R.N.; Douvdevani, A.; Huleihel, M.; Fima, E.; Hacham, M.; Shimoni, N.; Dvorkin, T.; Segal, S. 1992: IL-1 and pro-inflammatory cytokines produced by primary and transformed fibroblasts abrogate the tumorigenic potential of fibrosarcomas. Folia Biologica 38(3-4): 240-257
Yeh, Y.L.; Kang, Y.M.; Chaibi, M.S.; Xie, J.F.; Graves, D.T. 1993: IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression. Journal of Immunology 150(12): 5625-5632
Elias, J.A.; Zheng, T.; Whiting, N.L.; Trow, T.K.; Merrill, W.W.; Zitnik, R.; Ray, P.; Alderman, E.M. 1994: IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. Journal of Immunology 152(5): 2421-2429
Krakauer, T.; Oppenheim, J.J. 1993: IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). Journal of Immunology 150(4): 1205-1211
Kishihara, Y.; Hayashi, J.; Yoshimura, E.; Yamaji, K.; Nakashima, K.; Kashiwagi, S. 1996: IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Digestive Diseases and Sciences 41(2): 315-321
Verschure, P.J.; Joosten, L.A.; Van de Loo, F.A.; Van den Berg, W.B. 1995: IL-1 has no direct role in the IGF-1 non-responsive state during experimentally induced arthritis in mouse knee joints. Annals of the Rheumatic Diseases 54(12): 976-982
Osawa, Y.; Hachiya, M.; Koeffler, H.P.; Suzuki, G.; Akashi, M. 1995: IL-1 induces expression of WAF1 mRNA in human fibroblasts: mechanisms of accumulation. Biochemical and Biophysical Research Communications 216(2): 429-437
Takeshita, A.; Hanazawa, S.; Amano, S.; Matumoto, T.; Kitano, S. 1993: IL-1 induces expression of monocyte chemoattractant JE in clonal mouse osteoblastic cell line MC3T3-E1. Journal of Immunology 150(4): 1554-1562
Tsumara, H.; Wang, J.Z.; Ogawa, S.; Ohota, H.; Komada, H.; Ito, Y.; Shimura, K. 1994: IL-1 induces intracisternal type a virus and retrovirus type C in pancreatic beta-cells of NOD mice. Journal of Experimental Animal Science 36(4-5): 141-150
Introna, M.; Breviario, F.; d'Aniello, E.M.; Golay, J.; Dejana, E.; Mantovani, A. 1993: IL-1 inducible genes in human umbilical vein endothelial cells. European Heart Journal 14(Suppl): 78-81
Rozanski, G.J.; Witt, R.C. 1994: IL-1 inhibits beta-adrenergic control of cardiac calcium current: role of L-arginine/nitric oxide pathway. American Journal of Physiology 267(5 Pt 2): H1753-H1758
Sanz, M.J.; Weg, V.B.; Bolanowski, M.A.; Nourshargh, S. 1995: IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody. Journal of Immunology 154(3): 1364-1373
Fukumura, D.; Miura, S.; Kurose, I.; Higuchi, H.; Suzuki, H.; Ebinuma, H.; Han, J.Y.; Watanabe, N.; Wakabayashi, G.; Kitajima, M.; Ishii, H. 1996: IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Digestive Diseases and Sciences 41(12): 2482-2492
González-Hernández, J.A.; Bornstein, S.R.; Ehrhart-Bornstein, M.; Gschwend, J.E.; Gwosdow, A.; Jirikowski, G.; Scherbaum, W.A. 1995: IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis. Clinical and Experimental Immunology 99(1): 137-141
Le Maire, V.; Hernvann, A.; Le Marechal, H.; Ekindjian, O.G.; Aussel, C. 1997: IL-1 modifies system a transport activity in human rheumatoid synovial cells. Cell Biology International 21(7): 455-460
Arnush, M.; Heitmeier, M.R.; Scarim, A.L.; Marino, M.H.; Manning, P.T.; Corbett, J.A. 1998: IL-1 produced and released endogenously within human islets inhibits beta cell function. Journal of Clinical Investigation 102(3): 516-526
Perrier, S.; Coussediere, C.; Dubost, J.J.; Albuisson, E.; Sauvezie, B. 1998: IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. Clinical Immunology and Immunopathology 87(3): 309-313
Hurme, M.; Santtila, S. 1998: IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. European Journal of Immunology 28(8): 2598-2602
Damtew, B.; Rzewnicki, D.; Lozanski, G.; Kushner, I. 1993: IL-1 receptor antagonist affects the plasma protein response of Hep 3B cells to conditioned medium from lipopolysaccharide-stimulated monocytes. Journal of Immunology 150(9): 4001-4007
Lang, C.H.; Fan, J.; Cooney, R.; Vary, T.C. 1996: IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. American Journal of Physiology 270(3 Part 1): E430-E437
Langabeer, S.E.; Linch, D.C. 1998: IL-1 receptor antagonist gene polymorphism in patients with secondary acute myeloid leukaemia. Cytokines Cellular and Molecular Therapy 4(1): 7-9
Dubost, J.J.; Perrier, S.; Afane, M.; Viallard, J.L.; Roux-Lombard, P.; Baudet-Pommel, M.; Begue, C.; Kemeny, J.L.; Sauvezie, B. 1996: IL-1 receptor antagonist in saliva; characterization in normal saliva and reduced concentration in Sjögren's syndrome (SS). Clinical and Experimental Immunology 106(2): 237-242
Sandberg, J.O.; Eizirik, D.L.; Sandler, S. 1997: IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice. Clinical and Experimental Immunology 108(2): 314-317
Kline, J.N.; Monick, M.M.; Hunninghake, G.W. 1992: IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes. Journal of Applied Physiology 73(4): 1686-1692
Hinterleitner, T.A.; Saada, J.I.; Berschneider, H.M.; Powell, D.W.; Valentich, J.D. 1996: IL-1 stimulates intestinal myofibroblast COX gene expression and augments activation of Cl- secretion in T84 cells. American Journal of Physiology 271(4 Part 1): C1262-C1268
Leon, L.R.; Conn, C.A.; Glaccum, M.; Kluger, M.J. 1996: IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. American Journal of Physiology 271(6 Pt 2): R1668-R1675
Shu, S.; Naylor, P.; Touraine, J.L.; Hadden, J.W. 1996: IL-1, ICAM-1, LFA-3, and hydrocortisone differentially regulate cytokine secretion by human fetal thymic epithelial cells. Thymus 24(2): 89-99
Francus, T.; Romano, P.M.; Manzo, G.; Fonacier, L.; Arango, N.; Szabo, P. 1992: IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cellular Immunology 145(1): 156-174
Keisari, Y.; Seger, M.; Lengy, J.; Pauli, H.; Nathan, E.; Gold, D. 1993: IL-1, TNF-alpha and IL-2 production by peritoneal and spleen cells from Schistosoma mansoni infected mice and its potentiation by preimmunization with schistosomal antigens and immunostimulants. Immunobiology 188(4-5): 446-459
Yu, N.; Zhang, X.; Magistretti, P.J.; Bloom, F.E. 1998: IL-1-alpha and TNF-alpha differentially regulate CD4 and Mac-1 expression in mouse microglia. Neuroimmunomodulation 5(1-2): 42-52
Chirivi, R.G.; Chiodoni, C.; Musiani, P.; Garofalo, A.; Bernasconi, S.; Colombo, M.P.; Giavazzi, R. 1996: IL-1alpha gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. International Journal of Cancer 67(6): 856-863
Feliciani, C.; Amerio, P.; Pour, S.M.; Allegretti, T.; Proietto, G.; Coviello, C.; Amerio, P.; Vena, G.A. 1995: IL-1-alpha, IL-6 and TNF-alpha in cutaneous lesions of lupus erythematosus are inhibited by topical application of calcipotriol. International Journal of Immunopathology and Pharmacology 8(3): 199-207
Lieberman, D.; Livnat, S.; Schlaeffer, F.; Porath, A.; Horowitz, S.; Levy, R. 1997: IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection 25(2): 90-94
Corbett, J.A.; Kwon, G.; Turk, J.; McDaniel, M.L. 1993: IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32(50): 13767-13770
Hunter, C.A.; Chizzonite, R.; Remington, J.S. 1995: IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. Journal of Immunology 155(9): 4347-4354
Blanco, F.J.; Lotz, M. 1995: IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Experimental Cell Research 218(1): 319-325
Mccarron, R.M. 1992: IL-1-induced prostacyclin production by cerebral vascular endothelial cells inhibits myelin basic protein-specific lymphocyte proliferation. Cellular Immunology 145(1): 21-29
Li, L.; Elliott, J.F.; Mosmann, T.R. 1994: IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. Journal of Immunology 153(9): 3967-3978
Weissman, D.; Poli, G.; Fauci, A.S. 1995: IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 9(5): 442-449
Li, Y.Q.; Doyle, J.W.; Roth, T.P.; Dunn, R.M.; Lawrence, W.T. 1998: IL-10 and GM-CSF expression and the presence of antigen-presenting cells in chronic venous ulcers. Journal of Surgical Research 79(2): 128-135
Cohen, S.B. 1995: IL-10 and IL-3 synergize to cause proliferation of human T cells. Immunology 85(3): 351-356
Marconi, M.; Plebani, A.; Avanzini, M.A.; Maccario, R.; Pistorio, A.; Duse, M.; Stringa, M.; Monafo, V. 1998: IL-10 and IL-4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients. Clinical and Experimental Immunology 112(3): 528-532
Marie, C.; Pitton, C.; Fitting, C.; Cavaillon, J.M. 1996: IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Cytokine 8(2): 147-151
Punnonen, J.; de Waal Malefyt, R.; van Vlasselaer, P.; Gauchat, J.F.; de Vries, J.E. 1993: IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. Journal of Immunology 151(3): 1280-1289
Lenhoff, S.; Sallerfors, B.; Olofsson, T. 1998: IL-10 as an autocrine regulator of CSF secretion by monocytes: disparate effects on GM-CSF and G-CSF secretion. Experimental Hematology 26(4): 299-304
Spittler, A.; Schiller, C.; Willheim, M.; Tempfer, C.; Winkler, S.; Boltz-Nitulescu, G. 1995: IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology 85(2): 311-317
Salazar-Onfray, F.; Petersson, M.; Franksson, L.; Matsuda, M.; Blankenstein, T.; Kärre, K.; Kiessling, R. 1995: IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. Journal of Immunology 154(12): 6291-6298
Finnegan, A.; Roebuck, K.A.; Nakai, B.E.; Gu, D.S.; Rabbi, M.F.; Song, S.; Landay, A.L. 1996: IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. Journal of Immunology 156(2): 841-851
Sivo, J.; Vogel, S.N. 1996: IL-10 differentially regulates mRNA expression induced by lipopolysaccharide and interferons in murine peritoneal macrophages. Journal of Endotoxin Research 3(5): 407-414
Ehrlich, L.C.; Hu, S.; Peterson, P.K.; Chao, C.C. 1998: IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. Neuroreport 9(8): 1723-1726
Cox, G. 1996: IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. American Journal of Physiology 271(4 Part 1): L566-L571
de la Vega, J.R.; Vilaplana, J.C.; Biro, A.; Hammond, L.; Bottazzo, G.F.; Mirakian, R. 1998: IL-10 expression in thyroid glands: Protective or harmful role against thyroid autoimmunity?. Clinical and Experimental Immunology 113(1): 126-135
Cannella, B.; Gao, Y.L.; Brosnan, C.; Raine, C.S. 1996: IL-10 fails to abrogate experimental autoimmune encephalomyelitis. Journal of Neuroscience Research 45(6): 735-746
Hajeer, A.H.; Lazarus, M.; Turner, D.; Mageed, R.A.; Vencovsky, J.; Sinnott, P.; Hutchinson, I.V.; Ollier, W.E. 1998: IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scandinavian Journal of Rheumatology 27(2): 142-145
Rizzo, L.V.; Xu, H.; Chan, C.C.; Wiggert, B.; Caspi, R.R. 1998: IL-10 has a protective role in experimental autoimmune uveoretinitis. International Immunology 10(6): 807-814
Wehinger, J.; Gouilleux, F.; Groner, B.; Finke, J.; Mertelsmann, R.; Weber-Nordt, R.M. 1996: IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Letters 394(3): 365-370
Stearns, M.E.; Fudge, K.; Garcia, F.; Wang, M. 1997: IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression. Invasion and Metastasis 17(2): 62-74
Masood, R.; Lunardi-Iskandar, Y.; Moudgil, T.; Zhang, Y.; Law, R.E.; Huang, C.L.; Puri, R.K.; Levine, A.M.; Gill, P.S. 1994: IL-10 inhibits HIV-1 replication and is induced by Tat. Biochemical and Biophysical Research Communications 202(1): 374-383
Elia, J.M.; Hamilton, B.L.; Riley, R.L. 1995: IL-10 inhibits IL-7-mediated murine pre-B cell growth in vitro. Experimental Hematology 23(4): 323-327
Lindmark, E.; Tenno, T.; Chen, J.; Siegbahn, A. 1998: IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. British Journal of Haematology 102(2): 597-604
Peçanha, L.M.; Snapper, C.M.; Lees, A.; Yamaguchi, H.; Mond, J.J. 1993: IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. Journal of Immunology 150(8 Part 1): 3215-3223
Wang, L.; Goillot, E.; Tepper, R.I. 1994: IL-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cellular Immunology 159(2): 152-169
Taga, K.; Cherney, B.; Tosato, G. 1993: IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. International Immunology 5(12): 1599-1608
Ding, L.; Linsley, P.S.; Huang, L.Y.; Germain, R.N.; Shevach, E.M. 1993: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. Journal of Immunology 151(3): 1224-1234
Lacraz, S.; Nicod, L.P.; Chicheportiche, R.; Welgus, H.G.; Dayer, J.M. 1995: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. Journal of Clinical Investigation 96(5): 2304-2310
Niiro, H.; Otsuka, T.; Kuga, S.; Nemoto, Y.; Abe, M.; Hara, N.; Nakano, T.; Ogo, T.; Niho, Y. 1994: IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. International Immunology 6(4): 661-664
Krakauer, T. 1995: IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunology Letters 45(1-2): 61-65
Wu, J.; Cunha, F.Q.; Liew, F.Y.; Weiser, W.Y. 1993: IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. Journal of Immunology 151(8): 4325-4332
Wang, P.; Wu, P.; Siegel, M.I.; Egan, R.W.; Billah, M.M. 1994: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. Journal of Immunology 153(2): 811-816
Beissert, S.; Hosoi, J.; Grabbe, S.; Asahina, A.; Granstein, R.D. 1995: IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. Journal of Immunology 154(3): 1280-1286
Choe, J.; Choi, Y.S. 1998: IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells. European Journal of Immunology 28(2): 508-515
Asadullah, K.; Sterry, W.; Stephanek, K.; Jasulaitis, D.; Leupold, M.; Audring, H.; Volk, H.D.; Döcke, W.D. 1998: IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. Journal of Clinical Investigation 101(4): 783-794
Akridge, R.E.; Oyafuso, L.K.; Reed, S.G. 1994: IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. Journal of Immunology 153(12): 5782-5789
Arai, T.; Hiromatsu, K.; Kobayashi, N.; Takano, M.; Ishida, H.; Nimura, Y.; Yoshikai, Y. 1995: IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. Journal of Immunology 155(12): 5743-5749
Lee, M.S.; Mueller, R.; Wicker, L.S.; Peterson, L.B.; Sarvetnick, N. 1996: IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. Journal of Experimental Medicine 183(6): 2663-2668
Mussi, A.; Bonifati, C.; Carducci, M.; Viola, M.; Tomaselli, R.; Sacerdoti, G.; Fazio, M.; Ameglio, F. 1994: IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids. Journal of Biological Regulators and Homeostatic Agents 8(4): 117-120
Owens, J.M.; Gallagher, A.C.; Chambers, T.J. 1996: IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. Journal of Immunology 157(2): 936-940
Denis, M.; Ghadirian, E. 1993: IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. Journal of Immunology 151(10): 5425-5430
Rezende, S.A.; Silva-Teixeira, D.N.; Drummond, S.C.; Goes, A.M. 1997: IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes. Scandinavian Journal of Immunology 46(1): 96-102
Allavena, P.; Piemonti, L.; Longoni, D.; Bernasconi, S.; Stoppacciaro, A.; Ruco, L.; Mantovani, A. 1998: IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. European Journal of Immunology 28(1): 359-369
Oliva, A.; Scala, E.; Quinti, I.; Paganelli, R.; Ansotegui, I.J.; Giovannetti, A.; Pierdominici, M.; Aiuti, F.; Pandolfi, F. 1997: IL-10 production and CD40L expression in patients with common variable immunodeficiency. Scandinavian Journal of Immunology 46(1): 86-90
Williams, K.; Dooley, N.; Ulvestad, E.; Becher, B.; Antel, J.P. 1996: IL-10 production by adult human derived microglial cells. Neurochemistry International 29(1): 55-64
Zhou, Z.; Huang, R.; Danon, M.; Mayer, L.; Cunningham-Rundles, C. 1998: IL-10 production in common variable immunodeficiency. Clinical Immunology and Immunopathology 86(3): 298-304
Kim, J.; Modlin, R.L.; Moy, R.L.; Dubinett, S.M.; McHugh, T.; Nickoloff, B.J.; Uyemura, K. 1995: IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. Journal of Immunology 155(4): 2240-2247
Ishizaka, S.; Saito, S.; Yoshikawa, M.; Kimoto, M.; Nishiyama, T. 1996: IL-10 production in mouse hepatocytes augmented by TGF-beta. Cytokine 8(11): 837-843
Gelati, M.; Lamperti, E.; Dufour, A.; Corsini, E.; Venegoni, E.; Milanese, C.; Nespolo, A.; Salmaggi, A. 1997: IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: Preliminary findings. Italian Journal of Neurological Sciences 18(4): 191-194
Daftarian, P.M.; Kumar, A.; Kryworuchko, M.; Diaz-Mitoma, F. 1996: IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. Journal of Immunology 157(1): 12-20
Spera, P.A.; Ellison, J.A.; Feuerstein, G.Z.; Barone, F.C. 1998: IL-10 reduces rat brain injury following focal stroke. Neuroscience Letters 251(3): 189-192
Shparago, N.; Zelazowski, P.; Jin, L.; McIntyre, T.M.; Stuber, E.; Peçanha, L.M.; Kehry, M.R.; Mond, J.J.; Max, E.E.; Snapper, C.M. 1996: IL-10 selectively regulates murine Ig isotype switching. International Immunology 8(5): 781-790
te Velde, A.A.; de Waal Malefijt, R.; Huijbens, R.J.; de Vries, J.E.; Figdor, C.G. 1992: IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. Journal of Immunology 149(12): 4048-4052
Marcelletti, J.F.; Katz, D.H. 1996: IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cellular Immunology 167(1): 86-98
Kim, H.S.; Armstrong, D.; Hamilton, T.A.; Tebo, J.M. 1998: IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. Journal of Leukocyte Biology 64(1): 33-39
Bai, X.F.; Zhu, J.; Zhang, G.X.; Kaponides, G.; Höjeberg, B.; van der Meide, P.H.; Link, H. 1997: IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clinical Immunology and Immunopathology 83(2): 117-126
Lügering, N.; Kucharzik, T.; Stein, H.; Winde, G.; Lügering, A.; Hasilik, A.; Domschke, W.; Stoll, R. 1998: IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease. Digestive Diseases and Sciences 43(4): 706-714
Brunetti, M.; Colasante, A.; Mascetra, N.; Piantelli, M.; Musiani, P.; Aiello, F.B. 1998: IL-10 synergizes with dexamethasone in inhibiting human T cell proliferation. Journal of Pharmacology and Experimental Therapeutics 285(2): 915-919
Capsoni, F.; Minonzio, F.; Ongari, A.M.; Carbonelli, V.; Galli, A.; Zanussi, C. 1995: IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-gamma. Journal of Leukocyte Biology 58(3): 351-358
Jacobs, F.; Chaussabel, D.; Truyens, C.; Leclerq, V.; Carlier, Y.; Goldman, M.; Vray, B. 1998: IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: Improved control of Trypanosoma cruzi infection. Clinical and Experimental Immunology 113(1): 59-64
Friman, V.; Hanson, L.A.; Bridon, J.M.; Tarkowski, A.; Banchereau, J.; Brière, F. 1996: IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clinical and Experimental Immunology 104(3): 432-438
Rodriguez, M.H.; Arnaud, S.; Blanchet, J.P. 1995: IL-11 directly stimulates murine and human erythroid burst formation in semisolid cultures. Experimental Hematology 23(6): 545-550
Van de Ven, C.; Ishizawa, L.; Law, P.; Cairo, M.S. 1995: IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. Experimental Hematology 23(12): 1289-1295
Castagliuolo, I.; Kelly, C.P.; Qiu, B.S.; Nikulasson, S.T.; LaMont, J.T.; Pothoulakis, C. 1997: IL-11 inhibits Clostridium difficile toxin a enterotoxicity in rat ileum. American Journal of Physiology 273(2 Part 1): G333-G341
Frasca, D.; Pioli, C.; Guidi, F.; Pucci, S.; Arbitrio, M.; Leter, G.; Doria, G. 1996: IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. International Immunology 8(11): 1651-1657
Flynn, J.L.; Goldstein, M.M.; Triebold, K.J.; Sypek, J.; Wolf, S.; Bloom, B.R. 1995: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. Journal of Immunology 155(5): 2515-2524
Radrizzani, M.; Accornero, P.; Amidei, A.; Aiello, A.; Delia, D.; Kurrle, R.; Colombo, M.P. 1995: IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cellular Immunology 161(1): 14-21
Pearlman, E.; Heinzel, F.P.; Hazlett, F.E.; Kazura, J.W. 1995: IL-12 modulation of T helper responses to the filarial helminth, Brugia malayi. Journal of Immunology 154(9): 4658-4664
King, C.L.; Hakimi, J.; Shata, M.T.; Medhat, A. 1995: IL-12 regulation of parasite antigen-driven IgE production in human helminth infections. Journal of Immunology 155(1): 454-461
Schijns, V.E.; Haagmans, B.L.; Horzinek, M.C. 1995: IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice. Journal of Immunology 155(5): 2525-2532
Via, C.S.; Rus, V.; Gately, M.K.; Finkelman, F.D. 1994: IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. Journal of Immunology 153(9): 4040-4047
DeBlaker-Hohe, D.F.; Yamauchi, A.; Yu, C.R.; Horvath-Arcidiacono, J.A.; Bloom, E.T. 1995: IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cellular Immunology 165(1): 33-43
Alzona, M.; Jäck, H.M.; Fisher, R.I.; Ellis, T.M. 1995: IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells. Journal of Immunology 154(1): 9-16
Grohmann, U.; Belladonna, M.L.; Bianchi, R.; Orabona, C.; Ayroldi, E.; Fioretti, M.C.; Puccetti, P. 1998: IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 9(3): 315-323
Hoag, K.A.; Lipscomb, M.F.; Izzo, A.A.; Street, N.E. 1997: IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. American Journal of Respiratory Cell and Molecular Biology 17(6): 733-739
Gabrilovich, D.I.; Cunningham, H.T.; Carbone, D.P. 1996: IL-12 and mutant P53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 19(6): 414-418
Müller, G.; Saloga, J.; Germann, T.; Schuler, G.; Knop, J.; Enk, A.H. 1995: IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. Journal of Immunology 155(10): 4661-4668
Bertagnolli, M.M.; Lin, B.Y.; Young, D.; Herrmann, S.H. 1992: IL-12 augments antigen-dependent proliferation of activated T lymphocytes. Journal of Immunology 149(12): 3778-3783
Dybedal, I.; Larsen, S.; Jacobsen, S.E. 1995: IL-12 directly enhances in vitro murine erythropoiesis in combination with IL-4 and stem cell factor. Journal of Immunology 154(10): 4950-4955
Spencer, N.F.; Daynes, R.A. 1997: IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells: possible involvement in age-associated cytokine dysregulation. International Immunology 9(5): 745-754
de Barros-Mazon, S.; Guariento, M.E.; Abrahamsohn, I.A. 1997: IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen. Immunology Letters 57(1-3): 39-45
Wynn, T.A.; Jankovic, D.; Hieny, S.; Cheever, A.W.; Sher, A. 1995: IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. Journal of Immunology 154(9): 4701-4709
Wynn, T.A.; Jankovic, D.; Hieny, S.; Zioncheck, K.; Jardieu, P.; Cheever, A.W.; Sher, A. 1995: IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma. Journal of Immunology 154(8): 3999-4009
Benjamin, D.; Sharma, V.; Kubin, M.; Klein, J.L.; Sartori, A.; Holliday, J.; Trinchieri, G. 1996: IL-12 expression in AIDS-related lymphoma B cell lines. Journal of Immunology 156(4): 1626-1637
Yawalkar, N.; Brand, C.U.; Braathen, L.R. 1996: IL-12 gene expression in human skin-derived CD1a+ dendritic lymph cells. Archives of Dermatological Research 288(2): 79-84
Bhardwaj, N.; Seder, R.A.; Reddy, A.; Feldman, M.V. 1996: IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. Journal of Clinical Investigation 98(3): 715-722
Kelleher, P.; Knight, S.C. 1998: IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. International Immunology 10(6): 749-755
Grafte, S.; Lévêque, C.; Paysant, J.; Vasse, M.; Soria, C.; Vannier, J.P. 1998: IL-12 indirectly enhances proliferation of 5-FU-treated human hematopoietic peripheral blood CD34+ cells. American Journal of Hematology 58(3): 183-188
Xu, H.; Rizzo, L.V.; Caspi, R.R. 1995: IL-12 induces growth of the IL-4-dependent CT4S line and has a synergistic effect on IL-4-induced CT4S proliferation. Journal of Immunological Methods 181(2): 245-251
Wu, C.Y.; Demeure, C.; Kiniwa, M.; Gately, M.; Delespesse, G. 1993: IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. Journal of Immunology 151(4): 1938-1949
Godfrey, D.I.; Kennedy, J.; Gately, M.K.; Hakimi, J.; Hubbard, B.R.; Zlotnik, A. 1994: IL-12 influences intrathymic T cell development. Journal of Immunology 152(6): 2729-2735
DeKruyff, R.H.; Fang, Y.; Wolf, S.F.; Umetsu, D.T. 1995: IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells. Journal of Immunology 154(6): 2578-2587
Whitcup, S.M.; Rizzo, L.V.; Lai, J.C.; Hayashi, S.; Gazzinelli, R.; Chan, C.C. 1996: IL-12 inhibits endotoxin-induced inflammation in the eye. European Journal of Immunology 26(5): 995-999
Houssiau, F.A.; Mascart-Lemone, F.; Stevens, M.; Libin, M.; Devogelaer, J.P.; Goldman, M.; Renauld, J.C. 1997: IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clinical and Experimental Immunology 108(2): 375-380
Marshall, J.D.; Secrist, H.; DeKruyff, R.H.; Wolf, S.F.; Umetsu, D.T. 1995: IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. Journal of Immunology 155(1): 111-117
Williamson, E.; Garside, P.; Bradley, J.A.; Mowat, A.M. 1996: IL-12 is a central mediator of acute graft-versus-host disease in mice. Journal of Immunology 157(2): 689-699
Rao, J.B.; Chamberlain, R.S.; Bronte, V.; Carroll, M.W.; Irvine, K.R.; Moss, B.; Rosenberg, S.A.; Restifo, N.P. 1996: IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. Journal of Immunology 156(9): 3357-3365
Romani, L.; Mencacci, A.; Tonnetti, L.; Spaccapelo, R.; Cenci, E.; Puccetti, P.; Wolf, S.F.; Bistoni, F. 1994: IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. Journal of Immunology 153(11): 5167-5175
Bohn, E.; Autenrieth, I.B. 1996: IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. Journal of Immunology 156(4): 1458-1468
Aragane, Y.; Riemann, H.; Bhardwaj, R.S.; Schwarz, A.; Sawada, Y.; Yamada, H.; Luger, T.A.; Kubin, M.; Trinchieri, G.; Schwarz, T. 1994: IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. Journal of Immunology 153(12): 5366-5372
Zambello, R.; Trentin, L.; Cassatella, M.A.; Raimondi, R.; Cerutti, A.; Enthammer, C.; Facco, M.; Agostini, C.; Semenzato, G. 1996: IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. British Journal of Haematology 92(2): 308-314
Moiola, L.; Galbiati, F.; Martino, G.; Amadio, S.; Brambilla, E.; Comi, G.; Vincent, A.; Grimaldi, L.M.; Adorini, L. 1998: IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. European Journal of Immunology 28(8): 2487-2497
Zhou, P.; Sieve, M.C.; Bennett, J.; Kwon-Chung, K.J.; Tewari, R.P.; Gazzinelli, R.T.; Sher, A.; Seder, R.A. 1995: IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. Journal of Immunology 155(2): 785-795
Donckier, V.; Flamand, V.; Desalle, F.; Vanderhaeghen, M.L.; de Veerman, M.; Thielemans, K.; Abramowicz, D.; Goldman, M. 1998: IL-12 prevents neonatal induction of transplantation tolerance in mice. European Journal of Immunology 28(4): 1426-1430
Maruo, S.; Toyo-oka, K.; Oh-hora, M.; Tai, X.G.; Iwata, H.; Takenaka, H.; Yamada, S.; Ono, S.; Hamaoka, T.; Kobayashi, M.; Wysocka, M.; Trinchieri, G.; Fujiwara, H. 1996: IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. Journal of Immunology 156(5): 1748-1755
Sieling, P.A.; Wang, X.H.; Gately, M.K.; Oliveros, J.L.; McHugh, T.; Barnes, P.F.; Wolf, S.F.; Golkar, L.; Yamamura, M.; Yogi, Y.; Uyemura, K.; Rea, T.H.; Modlin, R.L. 1994: IL-12 regulates T helper type 1 cytokine responses in human infectious disease. Journal of Immunology 153(8): 3639-3647
Dias, S.; Boyd, R.; Balkwill, F. 1998: IL-12 regulates VEGF and MMPs in a murine breast cancer model. International Journal of Cancer 78(3): 361-365
Takahashi, I.; Nakagawa, I.; Xu, L.; Hamada, S. 1995: IL-12 rescues galactosamine-loaded mice from lethal shock triggered by Staphylococcal enterotoxin. Biochemical and Biophysical Research Communications 217(1): 74-80
Rook, A.H.; Kubin, M.; Cassin, M.; Vonderheid, E.C.; Vowels, B.R.; Wolfe, J.T.; Wolf, S.F.; Singh, A.; Trinchieri, G.; Lessin, S.R. 1995: IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. Journal of Immunology 154(3): 1491-1498
De Wit, D.; Flemming, C.L.; Harris, J.D.; Palmer, K.J.; Moore, J.S.; Gore, M.E.; Collins, M.K. 1996: IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL). Clinical and Experimental Immunology 105(2): 353-359
Jeannin, P.; Delneste, Y.; Seveso, M.; Life, P.; Bonnefoy, J.Y. 1996: IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. Journal of Immunology 156(9): 3159-3165
Kang, K.; Kubin, M.; Cooper, K.D.; Lessin, S.R.; Trinchieri, G.; Rook, A.H. 1996: IL-12 synthesis by human Langerhans cells. Journal of Immunology 156(4): 1402-1407
Yssel, H.; Fasler, S.; de Vries, J.E.; de Waal Malefyt, R. 1994: IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. International Immunology 6(7): 1091-1096
Segal, B.M.; Shevach, E.M. 1996: IL-12 unmasks latent autoimmune disease in resistant mice. Journal of Experimental Medicine 184(2): 771-775
Bliss, J.; Van Cleave, V.; Murray, K.; Wiencis, A.; Ketchum, M.; Maylor, R.; Haire, T.; Resmini, C.; Abbas, A.K.; Wolf, S.F. 1996: IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. Journal of Immunology 156(3): 887-894
Stevenson, M.M.; Tam, M.F.; Wolf, S.F.; Sher, A. 1995: IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. Journal of Immunology 155(5): 2545-2556
Meyaard, L.; Hovenkamp, E.; Otto, S.A.; Miedema, F. 1996: IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. Journal of Immunology 156(8): 2776-2782
Yu, W.G.; Ogawa, M.; Mu, J.; Umehara, K.; Tsujimura, T.; Fujiwara, H.; Hamaoka, T. 1997: IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways. Journal of Leukocyte Biology 62(4): 450-457
Poggi, A.; Costa, P.; Tomasello, E.; Moretta, L. 1998: IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. European Journal of Immunology 28(5): 1611-1616
Huang, S.K.; Xiao, H.Q.; Kleine-Tebbe, J.; Paciotti, G.; Marsh, D.G.; Lichtenstein, L.M.; Liu, M.C. 1995: IL-13 expression at the sites of allergen challenge in patients with asthma. Journal of Immunology 155(5): 2688-2694
Bochner, B.S.; Klunk, D.A.; Sterbinsky, S.A.; Coffman, R.L.; Schleimer, R.P. 1995: IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. Journal of Immunology 154(2): 799-803
Montaner, L.J.; Bailer, R.T.; Gordon, S. 1997: IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity. Journal of Leukocyte Biology 62(1): 126-132
Onoe, Y.; Miyaura, C.; Kaminakayashiki, T.; Nagai, Y.; Noguchi, K.; Chen, Q.R.; Seo, H.; Ohta, H.; Nozawa, S.; Kudo, I.; Suda, T. 1996: IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. Journal of Immunology 156(2): 758-764
Lefort, S.; Vita, N.; Reeb, R.; Caput, D.; Ferrara, P. 1995: IL-13 and IL-4 share signal transduction elements as well as receptor components in TF-1 cells. Febs Letters 366(2-3): 122-126
Cosentino, G.; Soprana, E.; Thienes, C.P.; Siccardi, A.G.; Viale, G.; Vercelli, D. 1995: IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. Journal of Immunology 155(6): 3145-3151
Fluckiger, A.C.; Brière, F.; Zurawski, G.; Bridon, J.M.; Banchereau, J. 1994: IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells. Immunology 83(3): 397-403
Rey, A.; M'rini, C.; Sozzani, P.; Lamboeuf, Y.; Beraud, M.; Caput, D.; Ferrara, P.; Pipy, B. 1998: IL-13 increases the cPLA2 gene and protein expression and the mobilization of arachidonic acid during an inflammatory process in mouse peritoneal macrophages. Biochimica Et Biophysica Acta 1393(2-3): 244-252
Lopez, M.; Amorim, L.; Gane, P.; Cristoph, A.; Bardinet, D.; Abina, A.M.; Minty, A.; Bernard, J. 1997: IL-13 induces CD34+ cells isolated from G-CSF mobilized blood to differentiate in vitro into potent antigen presenting cells. Journal of Immunological Methods 208(2): 117-119,. 27
Murata, T.; Noguchi, P.D.; Puri, R.K. 1996: IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. Journal of Immunology 156(8): 2972-2978
Cocks, B.G.; de Waal Malefyt, R.; Galizzi, J.P.; de Vries, J.E.; Aversa, G. 1993: IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. International Immunology 5(6): 657-663
Punnonen, J.; de Vries, J.E. 1994: IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B cells. Journal of Immunology 152(3): 1094-1102
Ghaffar, O.; Laberge, S.; Jacobson, M.R.; Lowhagen, O.; Rak, S.; Durham, S.R.; Hamid, Q. 1997: IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy. American Journal of Respiratory Cell and Molecular Biology 17(1): 17-24
Van Der Ploeg, I.; Jeddi Tehrani, M.; Matuseviciene, G.; Wahlgren, C.F.; Fransson, J.; Scheynius, A. 1997: IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation. Clinical and Experimental Immunology 109(3): 526-532
Till, S.; Durham, S.; Dickason, R.; Huston, D.; Bungre, J.; Walker, S.; Robinson, D.; Kay, A.B.; Corrigan, C. 1997: IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Immunology 91(1): 53-57
Takamatsu, Y.; Hasegawa, M.; Sato, S.; Takehara, K. 1998: IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis. Dermatology 196(4): 377-381
Li, H.; Sim, T.C.; Alam, R. 1996: IL-13 released by and localized in human basophils. Journal of Immunology 156(12): 4833-4838
Reisser, D.; Pinard, D.; Jeannin, J.F. 1996: IL-13 restores an in vitro specific cytolytic response of spleen cells from tumor-bearing rats. Journal of Leukocyte Biology 59(5): 728-732
Katz, Y.; Stav, D.; Barr, J.; Passwell, J.H. 1995: IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clinical and Experimental Immunology 101(1): 150-156
Piemonti, L.; Bernasconi, S.; Luini, W.; Trobonjaca, Z.; Minty, A.; Allavena, P.; Mantovani, A. 1995: IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. European Cytokine Network 6(4): 245-252
Urban, J.F.; Noben-Trauth, N.; Donaldson, D.D.; Madden, K.B.; Morris, S.C.; Collins, M.; Finkelman, F.D. 1998: IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8(2): 255-264
Katsanis, E.; Xu, Z.; Panoskaltsis-Mortari, A.; Weisdorf, D.J.; Widmer, M.B.; Blazar, B.R. 1996: IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice. Transplantation 62(6): 872-875
Armitage, R.J.; Macduff, B.M.; Eisenman, J.; Paxton, R.; Grabstein, K.H. 1995: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. Journal of Immunology 154(2): 483-490
Treiber-Held, S.; Stewart, D.M.; Kurman, C.C.; Nelson, D.L. 1996: IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells. Clinical Immunology and Immunopathology 79(1): 71-78
Allavena, P.; Giardina, G.; Bianchi, G.; Mantovani, A. 1997: IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. Journal of Leukocyte Biology 61(6): 729-735
Kivisäkk, P.; Matusevicius, D.; He, B.; Söderström, M.; Fredrikson, S.; Link, H. 1998: IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clinical and Experimental Immunology 111(1): 193-197
Evans, R.; Fuller, J.A.; Christianson, G.; Krupke, D.M.; Troutt, A.B. 1997: IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cellular Immunology 179(1): 66-73
Mori, A.; Suko, M.; Kaminuma, O.; Inoue, S.; Ohmura, T.; Nishizaki, Y.; Nagahori, T.; Asakura, Y.; Hoshino, A.; Okumura, Y.; Sato, G.; Ito, K.; Okudaira, H. 1996: IL-15 promotes cytokine production of human T helper cells. Journal of Immunology 156(7): 2400-2405
Giri, J.G.; Anderson, D.M.; Kumaki, S.; Park, L.S.; Grabstein, K.H.; Cosman, D. 1995: IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. Journal of Leukocyte Biology 57(5): 763-766
Fortunato, S.J.; Menon, R.; Lombardi, S.J. 1998: IL-15, a novel cytokine produced by human fetal membranes, is elevated in preterm labor. American Journal of Reproductive Immunology 39(1): 16-23
Bamford, R.N.; Battiata, A.P.; Waldmann, T.A. 1996: IL-15: the role of translational regulation in their expression. Journal of Leukocyte Biology 59(4): 476-480
Parada, N.A.; Cruikshank, W.W.; Danis, H.L.; Ryan, T.C.; Center, D.M. 1996: IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cellular Immunology 168(1): 100-106
Parnet, P.; Garka, K.E.; Bonnert, T.P.; Dower, S.K.; Sims, J.E. 1996: IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. Journal of Biological Chemistry 271(8): 3967-3970
Van Bezooijen, R.L.; Farih-Sips, H.C.; Papapoulos, S.E.; Löwik, C.W. 1998: IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 13(2): 185-194
Bode, H.; Schmitz, H.; Fromm, M.; Scholz, P.; Riecken, E.O.; Schulzke, J.D. 1998: IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon. Cytokine 10(6): 457-465
Kamikawa, H.; Hori, T.; Nakane, H.; Aou, S.; Tashiro, N. 1998: IL-1beta increases norepinephrine level in rat frontal cortex: involvement of prostanoids, NO, and glutamate. American Journal of Physiology 275(3): R803-R810
Mattsby-Baltzer, I.; Platz-Christensen, J.J.; Hosseini, N.; Rosén, P. 1998: IL-1beta, IL-6, TNFalpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstetricia et Gynecologica Scandinavica 77(7): 701-706
Parry, G.C.; Martin, T.; Felts, K.A.; Cobb, R.R. 1998: IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors. Arteriosclerosis Thrombosis and Vascular Biology 18(6): 934-940
Nishimura, T.; Abe, H.; Ito, H.; Ikeda, K.; Oka, F.; Yamamoto, M. 1998: IL-1ra versus IL-1 levels in prostatic fluid from prostatitis patients. Urologia Internationalis 60(2): 92-96
Bowman, L.; Grossmann, M.; Rill, D.; Brown, M.; Zhong, W.Y.; Alexander, B.; Leimig, T.; Coustan-Smith, E.; Campana, D.; Jenkins, J.; Woods, D.; Kitchingman, G.; Vanin, E.; Brenner, M. 1998: IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma. Blood 92(6): 1941-1949
Wang, J.; Hargrove, M.E.; Ting, C.C. 1996: IL-2 and IL-4 mediate through two distinct kinase pathways for the activation of alphaCD3-induced activated killer cells. Cellular Immunology 174(2): 138-146
Martinez, O.M.; Villanueva, J.C.; Lake, J.; Roberts, J.P.; Ascher, N.L.; Krams, S.M. 1993: IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 55(5): 1159-1166
Huberman, M.; Sredni, B.; Stern, L.; Kott, E.; Shalit, F. 1995: IL-2 and IL-6 secretion in dementia: Correlation with type and severity of disease. Journal of the Neurological Sciences 130(2): 161-164
Armant, M.; Delespesse, G.; Sarfati, M. 1995: IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology 85(2): 331-337
Bubenik, J.; Simova, J.; Vondrys, P.; Vonka, R.; Kitasato, H.; Bostik, P.; Vonka, V. 1996: IL-2 as adjuvant for vaccination with cells malignantly converted by HPV 16 or 3-MC. International Journal of Oncology 8(3): 477-481
Asano, M.; Ishida, Y.; Sabe, H.; Kondo, M.; Sugamura, K.; Honjo, T. 1994: IL-2 can support growth of CD8+ T cells but not CD4+ T cells of human IL-2 receptor beta-chain transgenic mice. Journal of Immunology 153(12): 5373-5381
Shao, Y.; Dai, R.Z.; Zhang, N.N. 1998: IL-2 combined with LAK cells in the treatment of malignant melanoma and cancers of kidney, liver, lung. Zhongguo Zhongliu Linchuang 25(2): 122-123
Metwali, A.; Elliott, D.; Mathew, R.; Blum, A.; Weinstock, J.V. 1993: IL-2 contributes to the IL-5 response in granulomas from mice infected with Schistosoma mansoni. Journal of Immunology 150(2): 536-542
Romano, M.F.; Turco, M.C.; Lamberti, A.; Tassone, P.; Venuta, S.; Formisano, S. 1993: IL-2 detection in supernatants of cultured peripheral blood mononuclear cells: Comparison of a biological assay with two different commercial ELISA assays. Immunologia Clinica 12(1): 13-20
López-Jiménez, J.; Quiroga, R.; Ramos, P.; Cerveró, C.; Parra, C.; García-Laraña, J.; Pérez-Oteyza, J.; Roldán, E.; Heindrichs, B.; Odriozola, J. 1996: IL-2 effects on allogeneic and autologous transplant haemopoietic progenitors in long-term cultures. Bone Marrow Transplantation 18(5): 899-905
Callaghan, M.; Whelan, A.; Feighery, C.; Bresnihan, B. 1993: IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells. Clinical and Experimental Immunology 93(2): 212-217
Bronte, V.; Tsung, K.; Rao, J.B.; Chen, P.W.; Wang, M.; Rosenberg, S.A.; Restifo, N.P. 1995: IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. Journal of Immunology 154(10): 5282-5292
Los, M.; Schenk, H.; Hexel, K.; Baeuerle, P.A.; Dröge, W.; Schulze-Osthoff, K. 1995: IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO Journal 14(15): 3731-3740
Tan, Y.; Xu, M.; Wang, W.; Zhang, F.; Li, D.; Xu, X.; Gu, J.; Hoffman, R.M. 1996: IL-2 gene therapy of advanced lung cancer patients. Anticancer Research 16(4a): 1993-1998
Zier, K.S.; Gansbacher, B. 1996: IL-2 gene therapy of solid tumors: An approach for the prevention of signal transduction defects in T cells. Journal of Molecular Medicine 74(3): 127-134
Medveczky, M.M.; Geck, P.; Sullivan, J.L.; Serbousek, D.; Djeu, J.Y.; Medveczky, P.G. 1993: IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology 196(2): 402-412
Matsuzawa, S.; Matsuda, A.; Mizuno, Y.; Kikuchi, K. 1993: IL-2 induces transient and specific decrease in cytosolic protein phosphatase PP1 activity in murine T cell lines. Biochemical and Biophysical Research Communications 195(2): 989-996
Raber, J.; Bloom, F.E. 1994: IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(10): 6187-6195
Nakanishi, K.; Yoshimoto, T.; Chu, C.C.; Matsumoto, H.; Hase, K.; Nagai, N.; Tanaka, T.; Miyasaka, M.; Paul, W.E.; Shinka, S. 1995: IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo. International Immunology 7(2): 259-268
Szebeni, J.; Wang, M.G.; Pearson, D.A.; Szot, G.L.; Sykes, M. 1994: IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Transplantation 58(12): 1385-1393
Dilloo, D.; Hanenberg, H.; Lion, T.; Burdach, S. 1995: IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein. Leukemia 9(3): 419-424
Zaloom, Y.; Gallagher, G. 1993: IL-2 inhibits the induction of systemic antitumour immunity by IL-4 in the peritumoural treatment of experimental melanoma. Anticancer Research 13(4): 1081-1085
Steiger, J.; Nickerson, P.W.; Steurer, W.; Moscovitch-Lopatin, M.; Strom, T.B. 1995: IL-2 knockout recipient mice reject islet cell allografts. Journal of Immunology 155(1): 489-498
Bill, O.; Garlisi, C.G.; Grove, D.S.; Holt, G.E.; Mastro, A.M. 1994: IL-2 mRNA levels and degradation rates change with mode of stimulation and phorbol ester treatment of lymphocytes. Cytokine 6(1): 102-110
Okuno, K.; Kobayashi, S.; Jinnai, H.; Lee, Y.S.; Shigeoka, H.; Yasutomi, M. 1996: IL-2 perfusion to the liver augments the hepatic extraction rate of accompanying anticancer drugs. Surgery Today 26(8): 662-664
Alileche, A.; Han, D.; Plaisance, S.; Assier, E.; Sahraoui, Y.; Clemanceau, C.; Metivier, D.; Brouty-Boyer, D.; Jasmin, C.; Azzarone, B. 1994: IL-2 production by myofibroblasts from post-radiation fibrosis in breast cancer patients. International Immunology 6(10): 1585-1591
Brombacher, F.; Schäfer, T.; Weissenstein, U.; Tschopp, C.; Andersen, E.; Bürki, K.; Baumann, G. 1994: IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. International Immunology 6(2): 189-197
Rolink, A.; Grawunder, U.; Winkler, T.H.; Karasuyama, H.; Melchers, F. 1994: IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. International Immunology 6(8): 1257-1264
Chen, J.; Ma, A.; Young, F.; Alt, F.W. 1994: IL-2 receptor alpha chain expression during early B lymphocyte differentiation. International Immunology 6(8): 1265-1268
Ihan, A.; Tepez, B.; Kavcic, I.; Gubina, M. 1996: Il-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients. Hepato-Gastroenterology 43(12): 1665-1670
Itano, M.; Tsuchiya, S.; Morita, S.; Fujie, H.; Ishii, N.; Yanagisawa, T.; Ohashi, Y.; Minegishi, M.; Sugamura, K.; Konno, T. 1996: IL-2 receptor gamma chain expression on CD34 positive hematopoietic progenitor cells from bone marrow and cord blood. Tohoku Journal of Experimental Medicine 178(4): 389-398
Bessler, H.; Sirota, L.; Notti, I.; Milo, T.; Djaldetti, M. 1993: IL-2 receptor gene expression and IL-2 production by human preterm newborns' cells. Clinical and Experimental Immunology 93(3): 479-483
Rebollo, A.; Silva, A. 1994: IL-2 receptor: Structure and function. Inmunologia 13(2): 39-47
Teodorczyk-Injeyan, J.A.; Sparkes, B.G.; Lalani, S.; Peters, W.J.; Mills, G.B. 1992: IL-2 regulation of soluble IL-2 receptor levels following thermal injury. Clinical and Experimental Immunology 90(1): 36-42
Mor, F.; Cohen, I.R. 1996: IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2. Journal of Immunology 156(2): 515-522
Schols, D.; Vandekerckhove, B.; Jones, D.; Roncarolo, M.G. 1994: IL-2 reverses human T cell unresponsiveness induced by thymic epithelium in SCID-hu mice. Journal of Immunology 152(5): 2198-2206
Yoneda, K.; Osaki, T.; Yamamoto, T. 1996: IL-2 signalling in T and natural killer (NK) cells associated with their class I-non-restricted killing activity. Clinical and Experimental Immunology 106(1): 179-186
Watts, J.D.; Welham, M.J.; Kalt, L.; Schrader, J.W.; Aebersold, R. 1993: IL-2 stimulation of T lymphocytes induces sequential activation of mitogen-activated protein kinases and phosphorylation of p56lck at serine-59. Journal of Immunology 151(12): 6862-6871
Boyano, M.D.; Garcia de Galdeano, A.; Smith-Zubiaga, I.; Cañavate, M.L. 1997: IL-2 treatment of B16F10 melanoma cells stimulates metastatic colonization in the liver. Anticancer Research 17(2a): 1135-1141
Gusella, G.L.; Musso, T.; Bosco, M.C.; Espinoza-Delgado, I.; Matsushima, K.; Varesio, L. 1993: IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. Journal of Immunology 151(5): 2725-2732
Hladik, F.; Kolbe, K.; Irschick, E.U.; Aman, M.J.; Gerken, G.; Färber, L.; Liehl, E.; Peschel, C.; Aulitzky, W.E.; Huber, C. 1993: IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P). Annals of Hematology 67(2): 67-74
Lagoo, A.S.; Lagoo-Deenadayalan, S.; Lorenz, H.M.; Byrne, J.; Barber, W.H.; Hardy, K.J. 1994: IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules. Journal of Immunology 152(4): 1641-1652
Plotnicky, H.; Cyblat, D.; Vernant, J.C.; Desgranges, C. 1994: IL-2-dependent HTLV-I-infected T cells escape from non-specific, MHC-unrestricted cellular cytotoxicity. Clinical Immunology and Immunopathology 73(2): 205-214
Turner, J.M. 1993: IL-2-dependent induction of G1 cyclins in primary T cells is not blocked by rapamycin or cyclosporin A. International Immunology 5(10): 1199-1209
Kos, F.J.; Müllbacher, A. 1993: IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. Journal of Immunology 150(2): 387-393
Sykes, M.; Pearson, D.A.; Szot, G.L. 1995: IL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation. Bone Marrow Transplantation 15(3): 395-399
Schmandt, R.; Hill, M.; Amendola, A.; Mills, G.B.; Hogg, D. 1994: IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression. Journal of Immunology 152(1): 96-105
Adachi, M.; Torigoe, T.; Sekiya, M.; Minami, Y.; Taniguchi, T.; Hinoda, Y.; Yachi, A.; Reed, J.C.; Imai, K. 1995: IL-2-induced gene expression of protein-tyrosine phosphatase LC-PTP requires acidic and serine-rich regions within IL-2 receptor beta chain. Febs Letters 372(1): 113-118
Arima, N.; Matsushita, K.; Suruga, Y.; Ohtsubo, H.; Fujiwara, H.; Hidaka, S.; Arimura, K.; Kukita, T.; Yamaguchi, K.; Fukumori, J.; Tanaka, H. 1998: IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-kappaB induction and IL-2 receptor alpha expression. Leukemia Research 22(3): 265-273
Krulová, M.; Havelková, H.; Kosarová, M.; Holán, V.; Hart, A.A.; Demant, P.; Lipoldová, M. 1997: IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: a distinct control of the response induced by different IL-2 concentrations. Genomics 42(1): 11-15
MacGlashan, D.W.; Hubbard, W.C. 1993: IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils. Journal of Immunology 151(11): 6358-6369
Matsumoto, S.; Hamasaki, Y.; Ichimaru, T.; Miyazaki, S. 1995: IL-3 and IL-5 enhance the production of LTB4 stimulated by calcium ionophore in rat basophilic leukemia cells. Prostaglandins Leukotrienes and Essential Fatty Acids 52(6): 417-422
Majumdar, A.; Kerby, S.; Stenberg, P.E.; Mullikin, B.; Beckstead, J.H.; Cooney, D.A.; Seidman, M.M. 1994: IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line. Journal of Cellular Physiology 160(1): 29-39
Snapper, C.M.; Moorman, M.A.; Rosas, F.R.; Kehry, M.R.; Maliszewski, C.R.; Mond, J.J. 1995: IL-3 and granulocyte-macrophage colony-stimulating factor strongly induce Ig secretion by sort-purified murine B cell activated through the membrane Ig, but not the CD40, signaling pathway. Journal of Immunology 154(11): 5842-5850
Majumdar, A.; Kerby, S.; Mullikin, B.; Beckstead, J.H.; Stenberg, P.E.; Seidman, M.M. 1995: IL-3 and ribavirin induce differentiation and growth suppression during long-term treatment of a megakaryocytic leukemia cell line. Journal of Cellular Physiology 165(3): 530-537
Dan, Y.; Katakura, Y.; Ametani, A.; Kaminogawa, S.; Asano, Y. 1996: IL-3 augments TCR-mediated responses of type 2 CD4 T cells. Journal of Immunology 156(1): 27-34
Harada, M.; Sumichika, H.; Hamano, S.; Ito, O.; Tamada, K.; Takenoyama, M.; Kimura, G.; Nomoto, K. 1996: IL-3 derived from CD4+ T cells is essential for the in vitro expansion of mast cells from the normal adult mouse spleen. Clinical and Experimental Immunology 106(1): 149-155
Thomssen, H.; Kahan, M.; Londei, M. 1996: IL-3 in combination with IL-4, induces the expression of functional CD1 molecules on monocytes. Cytokine 8(6): 476-481
Eder, M.; Geissler, G.; Ganser, A. 1997: IL-3 in the clinic. Stem Cells 15(5): 327-333
Bastion, Y.; Campos, L.; Roubi, N.; Bienvenu, J.; Felman, P.; Dumontet, C.; Coiffier, B. 1995: IL-3 increases marrow and peripheral erythroid precursors in chronic pure red cell aplasia presenting in childhood. British Journal of Haematology 89(2): 413-416
Conget, P.; Minguell, J.J. 1995: IL-3 increases surface proteoglycan synthesis in haemopoietic progenitors and their adhesiveness to the heparin-binding domain of fibronectin. British Journal of Haematology 89(1): 1-7
Gibson, F.M.; Scopes, J.; Daly, S.; Rizzo, S.; Ball, S.E.; Gordon-Smith, E.C. 1995: IL-3 is produced by normal stroma in long-term bone marrow cultures. British Journal of Haematology 90(3): 518-525
Panterne, B.; Hatzfeld, A.; Sansilvestri, P.; Cardoso, A.; Monier, M.N.; Batard, P.; Hatzfeld, J. 1996: IL-3, GM-CSF and CSF-1 modulate c-fms mRNA more rapidly in human early monocytic progenitors than in mature or transformed monocytic cells. Journal of Cell Science 109: 1795-1801
Sarmiento, E.U.; Espiritu, B.R.; Gleich, G.J.; Thomas, L.L. 1995: IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. Journal of Immunology 155(4): 2211-2221
Yamada, T.; Sun, Q.; Zeibecoglou, K.; Bungre, J.; North, J.; Kay, A.B.; Lopez, A.F.; Robinson, D.S. 1998: IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells. Journal of Allergy and Clinical Immunology 101(5): 677-682
Tedeschi, A.; Palella, M.; Milazzo, N.; Lorini, M.; Miadonna, A. 1995: IL-3-induced histamine release from human basophils. Dissociation from cationic dye binding and down-regulation by Na+ and K+. Journal of Immunology 155(5): 2652-2660
Djaldetti, R.; Achiron, A.; Ziv, I.; Djaldetti, M.; Melamed, E.; Fishman, P. 1995: IL-3-LA production by mononuclear cells of patients with multiple sclerosis: effect of treatment with intravenous immunoglobulins. Immunological Investigations 24(5): 765-773
Bianchine, P.J.; Burd, P.R.; Metcalfe, D.D. 1992: IL-3-dependent mast cells attach to plate-bound vitronectin. Demonstration of augmented proliferation in response to signals transduced via cell surface vitronectin receptors. Journal of Immunology 149(11): 3665-3671
Mekori, Y.A.; Oh, C.K.; Metcalfe, D.D. 1993: IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. Journal of Immunology 151(7): 3775-3784
Lord, E.M.; Yeh, K.Y.; Moran, J.A.; Storozynsky, E.; Frelinger, J.G. 1998: IL-3-mediated enhancement of particulate antigen presentation by macrophages. Journal of ImmunoTherapy 21(3): 205-210
Urban, J.F.; Maliszewski, C.R.; Madden, K.B.; Katona, I.M.; Finkelman, F.D. 1995: IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. Journal of Immunology 154(9): 4675-4684
Nagelkerken, L.; Blauw, B.; Tielemans, M. 1997: IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. International Immunology 9(9): 1243-1251
Wang, L.M.; Keegan, A.D.; Paul, W.E.; Heidaran, M.A.; Gutkind, J.S.; Pierce, J.H. 1992: IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO Journal 11(13): 4899-4908
Rougier, N.; Schmitt, D.; Vincent, C. 1998: IL-4 addition during differentiation of CD34 progenitors delays maturation of dendritic cells while promoting their survival. European Journal of Cell Biology 75(3): 287-293
Parronchi, P.; De Carli, M.; Manetti, R.; Simonelli, C.; Sampognaro, S.; Piccinni, M.P.; Macchia, D.; Maggi, E.; Del Prete, G.; Romagnani, S. 1992: IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. Journal of Immunology 149(9): 2977-2983
Denning, G.M. 1996: IL-4 and IFN-gamma synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. Role of protein tyrosine kinases. Journal of Immunology 156(12): 4807-4814
Deckers, J.G.; De Haij, S.; van der Woude, F.J.; van der Kooij, S.W.; Daha, M.R.; van Kooten, C. 1998: IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. Journal of the American Society of Nephrology: Jasn 9(7): 1187-1193
Etter, H.; Althaus, R.; Eugster, H.P.; Santamaria-Babi, L.F.; Weber, L.; Moser, R. 1998: IL-4 and IL-13 downregulate rolling adhesion of leukocytes to IL-1 or TNF-alpha-activated endothelial cells by limiting the interval of E-selectin expression. Cytokine 10(6): 395-403
Herbert, J.M.; Savi, P.; Laplace, M.C.; Lalé, A.; Dol, F.; Dumas, A.; Labit, C.; Minty, A. 1993: IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. Febs Letters 328(3): 268-270
al Ghamdi, K.; Ghaffar, O.; Small, P.; Frenkiel, S.; Hamid, Q. 1997: IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. Journal of Otolaryngology 26(3): 160-166
Mikovits, J.A.; Meyers, A.M.; Ortaldo, J.R.; Minty, A.; Caput, D.; Ferrara, P.; Ruscetti, F.W. 1994: IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes. Journal of Leukocyte Biology 56(3): 340-346
Musso, T.; Varesio, L.; Zhang, X.; Rowe, T.K.; Ferrara, P.; Ortaldo, J.R.; O'Shea, J.J.; McVicar, D.W. 1994: IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. Journal of Experimental Medicine 180(6): 2383-2388
Kambayashi, T.; Jacob, C.O.; Strassmann, G. 1996: IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cellular Immunology 171(1): 153-158
Lind, M.; Deleuran, B.; Yssel, H.; Fink-Eriksen, E.; Thestrup-Pedersen, K. 1995: IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine 7(1): 78-82
Or, R.; Renz, H.; Terada, N.; Gelfand, E.W. 1992: IL-4 and IL-2 promote human T-cell proliferation through symmetrical but independent pathways. Clinical Immunology and Immunopathology 64(3): 210-217
Humbert, M.; Durham, S.R.; Ying, S.; Kimmitt, P.; Barkans, J.; Assoufi, B.; Pfister, R.; Menz, G.; Robinson, D.S.; Kay, A.B.; Corrigan, C.J. 1996: IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. American Journal of Respiratory and Critical Care Medicine 154(5): 1497-1504
Saneyoshi, K.; Nohara, O.; Imai, T.; Shiraishi, F.; Moriyama, H.; Fujimaki, H. 1997: IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by treatment with environmental pollutants. International Archives of Allergy and Immunology 114(3): 237-245
Herzberg, F.; Schöning, M.; Schirner, M.; Topp, M.; Thiel, E.; Kreuser, E.D. 1996: IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells. Clinical and Experimental Metastasis 14(2): 165-175
Nakanishi, K.; Matsui, K.; Kashiwamura, S.; Nishioka, Y.; Nomura, J.; Nishimura, Y.; Sakaguchi, N.; Yonehara, S.; Higashino, K.; Shinka, S. 1996: IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation. International Immunology 8(5): 791-798
Tang, M.; Kemp, A.; Varigos, G. 1993: IL-4 and interferon-gamma production in children with atopic disease. Clinical and Experimental Immunology 92(1): 120-124
Katamura, K.; Fukui, T.; Kiyomasu, T.; Iio, J.; Tai, G.; Ueno, H.; Heike, T.; Mayumi, M.; Furusho, K. 1998: IL-4 and prostaglandin E2 inhibit hypomethylation of the 5' regulatory region of IFN-gamma gene during differentiation of naive CD4+ T cells. Molecular Immunology 35(1): 39-45
Ricci, M.; Matucci, A.; Rossi, O. 1997: IL-4 as a key factor influencing the development of allergen-specific Th2-like cells in atopic individuals. Journal of Investigational Allergology and Clinical Immunology 7(3): 144-150
Larner, A.C.; Petricoin, E.F.; Nakagawa, Y.; Finbloom, D.S. 1993: IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines. Journal of Immunology 150(5): 1944-1950
Moser, R.; Fehr, J.; Bruijnzeel, P.L. 1992: IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. Journal of Immunology 149(4): 1432-1438
Colgan, S.P.; Resnick, M.B.; Parkos, C.A.; Delp-Archer, C.; McGuirk, D.; Bacarra, A.E.; Weller, P.F.; Madara, J.L. 1994: IL-4 directly modulates function of a model human intestinal epithelium. Journal of Immunology 153(5): 2122-2129
Ebert, E.C.; Roberts, A.I. 1996: IL-4 down-regulates the responsiveness of human intraepithelial lymphocytes. Clinical and Experimental Immunology 105(3): 556-560
McGee, D.W.; Vitkus, S.J. 1996: IL-4 enhances IEC-6 intestinal epithelial cell proliferation yet has no effect on IL-6 secretion. Clinical and Experimental Immunology 105(2): 274-277
Buckley, M.G.; Williams, C.M.; Thompson, J.; Pryor, P.; Ray, K.; Butterfield, J.H.; Coleman, J.W. 1995: IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 84(3): 410-415
Gundel, R.; Lindell, D.; Harris, P.; Fournel, M.; Jesmok, G.; Gerritsen, M.E. 1996: IL-4 induced leucocyte trafficking in cynomolgus monkeys: Correlation with expression of adhesion molecules and chemokine generation. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 26(6): 719-729
Bober, L.A.; Waters, T.A.; Pugliese-Sivo, C.C.; Sullivan, L.M.; Narula, S.K.; Grace, M.J. 1995: IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clinical and Experimental Immunology 99(1): 129-136
Dugas, B.; Paul-Eugene, N.; Yamaoka, K.; Amirand, C.; Damais, C.; Kolb, J.P. 1995: IL-4 induces cAMP and cGMP in human monocytic cells. Mediators of Inflammation 4(4): 298-305
Dubois, G.R.; Bruijnzeel-Koomen, C.A.; Bruijnzeel, P.L. 1994: IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals. Journal of Investigative Dermatology 102(6): 843-846
Punnonen, J.; Cocks, B.G.; de Vries, J.E. 1995: IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. Journal of Immunology 155(9): 4248-4254
Carballido, J.M.; Schols, D.; Namikawa, R.; Zurawski, S.; Zurawski, G.; Roncarolo, M.G.; de Vries, J.E. 1995: IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist. Journal of Immunology 155(9): 4162-4170
Mandler, R.; Finkelman, F.D.; Levine, A.D.; Snapper, C.M. 1993: IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching. Journal of Immunology 150(2): 407-418
Palmer-Crocker, R.L.; Pober, J.S. 1995: IL-4 induction of VCAM-1 on endothelial cells involves activation of a protein tyrosine kinase. Journal of Immunology 154(6): 2838-2845
Colquhoun, S.D.; Economou, J.S.; Shau, H.; Golub, S.H. 1993: IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. Journal of Surgical Research 55(5): 486-492
Tambur, A.R.; Markham, P.N.; Gebel, H.M. 1998: IL-4 inhibits P-glycoprotein in normal and malignant NK cells. Human Immunology 59(8): 483-487
Paganin, C.; Matteucci, C.; Cenzuales, S.; Mantovani, A.; Allavena, P. 1994: IL-4 inhibits binding and cytotoxicity of NK cells to vascular endothelium. Cytokine 6(2): 135-140
Dechanet, J.; Briolay, J.; Rissoan, M.C.; Chomarat, P.; Galizzi, J.P.; Banchereau, J.; Miossec, P. 1993: IL-4 inhibits growth factor-stimulated rheumatoid synoviocyte proliferation by blocking the early phases of the cell cycle. Journal of Immunology 151(9): 4908-4917
Quentmeier, H.; Kolsdorf, K.; Zaborski, M.; Drexler, H.G. 1994: IL-4 inhibits the LPS-induced expression of CD14 and monocyte-specific esterase mRNA in MONO-MAC-6 cells. Leukemia 8(9): 1551-1556
Inobe, J.; Slavin, A.J.; Komagata, Y.; Chen, Y.; Liu, L.; Weiner, H.L. 1998: IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. European Journal of Immunology 28(9): 2780-2790
Dieli, F.; Asherson, G.L.; Romano, G.C.; Sireci, G.; Gervasi, F.; Salerno, A. 1994: IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells. Journal of Immunology 152(6): 2698-2704
Watson, C.J.; Finlay-Jones, J.J.; McDonald, P.J.; Hart, P.H. 1995: IL-4 mRNA expression by peritoneal cells during episodes of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clinical and Experimental Immunology 100(2): 253-261
Frandji, P.; Mourad, W.; Tkaczyk, C.; Singer, M.; David, B.; Colle, J.H.; Mécheri, S. 1998: IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. European Journal of Immunology 28(3): 844-854
Kasaian, M.T.; Clay, M.J.; Happ, M.P.; Garman, R.D.; Hirani, S.; Luqman, M. 1996: IL-4 production by allergen-stimulated primary cultures: identification of basophils as the major IL-4-producing cell type. International Immunology 8(8): 1287-1297
Fujimaki, H.; Nohara, O.; Ichinose, T.; Watanabe, N.; Saito, S. 1994: IL-4 production in mediastinal lymph node cells in mice intratracheally instilled with diesel exhaust particulates and antigen. Toxicology 92(1-3): 261-268
Byron, K.A.; Varigos, G.A.; Wootton, A.M. 1994: IL-4 production is increased in cigarette smokers. Clinical and Experimental Immunology 95(2): 333-336
Nicholls, S.E.; Heyworth, C.M.; Dexter, T.M.; Lord, J.M.; Johnson, G.D.; Whetton, A.D. 1995: IL-4 promotes macrophage development by rapidly stimulating lineage restriction of bipotent granulocyte-macrophage colony-forming cells. Journal of Immunology 155(2): 845-853
Degiannis, D.; Hornung, N.; Luke-Gustites, D.; Raskova, J.; Raska, K. 1993: IL-4 receptor expression by SAC-activated B-lymphocytes: its role in B-cell proliferation and the effect of cyclosporine (CsA), prednisolone and verapamil. International Journal of Immunopharmacology 15(7): 829-832
Arruda, S.; Ho, J.L. 1992: IL-4 receptor signal transduction in human monocytes is associated with protein kinase C translocation. Journal of Immunology 149(4): 1258-1264
Fenton, M.J.; Buras, J.A.; Donnelly, R.P. 1992: IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. Journal of Immunology 149(4): 1283-1288
Klein, N.J.; Rigley, K.P.; Callard, R.E. 1993: IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. International Immunology 5(3): 293-301
Arock, M.; Merle-Béral, H.; Dugas, B.; Ouaaz, F.; Le Goff, L.; Vouldoukis, I.; Mencia-Huerta, J.M.; Schmitt, C.; Leblond-Missenard, V.; Debre, P. 1993: IL-4 release by human leukemic and activated normal basophils. Journal of Immunology 151(3): 1441-1447
Egger, D.; Geuenich, S.; Denzlinger, C.; Schmitt, E.; Mailhammer, R.; Ehrenreich, H.; Dörmer, P.; Hültner, L. 1995: IL-4 renders mast cells functionally responsive to endothelin-1. Journal of Immunology 154(4): 1830-1837
Schroeder, J.T.; Howard, B.P.; Jenkens, M.K.; Kagey-Sobotka, A.; Lichtenstein, L.M.; MacGlashan, D.W. 1998: IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation. Journal of Leukocyte Biology 63(6): 692-698
Yanagisawa, K.; Hatta, N.; Watanabe, I.; Horiuchi, T.; Hasegawa, H.; Fujita, S. 1995: IL-4 stimulates the growth of chronic myelomonocytic leukemia cells (CMMoL) once leukemic transformation has occurred. Leukemia 9(6): 1056-1059
Punnonen, J.; Kainulainen, L.; Ruuskanen, O.; Nikoskelainen, J.; Arvilommi, H. 1997: IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency. Scandinavian Journal of Immunology 45(2): 203-212
DeKruyff, R.H.; Fang, Y.; Secrist, H.; Umetsu, D.T. 1995: IL-4 synthesis by in vivo-primed memory CD4+ T cells: II. Presence of IL-4 is not required for IL-4 synthesis in primed CD4+ T cells. Journal of Clinical Immunology 15(2): 105-115
Stack, R.M.; Lenschow, D.J.; Gray, G.S.; Bluestone, J.A.; Fitch, F.W. 1994: IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. Journal of Immunology 152(12): 5723-5733
Terada, N.; Konno, A.; Terada, Y.; Fukuda, S.; Yamashita, T.; Abe, T.; Shimada, H.; Ishida, K.; Yoshimura, K.; Tanaka, Y.; Ra, C.; Ishikawa, K.; Togawa, K. 1995: IL-4 upregulates FceRI alpha-chain messenger RNA in eosinophils. Journal of Allergy and Clinical Immunology 96(6 Part 2): 1161-1169
Pindolia, K.R.; Noth, C.J.; Xu, Y.X.; Janakiraman, N.; Chapman, R.A.; Gautam, S.C. 1996: IL-4 upregulates IL-1-induced chemokine gene expression in bone marrow stromal cells by enhancing NF-kB activation. Hematopathology and Molecular Hematology 10(4): 171-185
Makhluf, H.A.; Stepniakowska, J.; Hoffman, S.; Smith, E.; LeRoy, E.C.; Trojanowska, M. 1996: IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. Journal of Investigative Dermatology 107(6): 856-859
Kucharzik, T.; Lügering, N.; Pauels, H.G.; Domschke, W.; Stoll, R. 1998: IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clinical and Experimental Immunology 111(1): 152-157
Erb, K.J.; Kirman, J.; Delahunt, B.; Chen, W.; Le Gros, G. 1998: IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunology and Cell Biology 76(1): 41-46
Brummer, E.; Hanson, L.H.; Stevens, D.A. 1993: IL-4, IgE, and interferon-gamma production in pulmonary blastomycosis: comparison in mice untreated, immunized, or treated with an antifungal (SCH 39304). Cellular Immunology 149(2): 258-267
Galéa, P.; Thibault, G.; Lacord, M.; Bardos, P.; Lebranchu, Y. 1993: IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway. Journal of Immunology 151(2): 588-596
Barata, L.T.; Ying, S.; Meng, Q.; Barkans, J.; Rajakulasingam, K.; Durham, S.R.; Kay, A.B. 1998: IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Journal of Allergy and Clinical Immunology 101(2 Part 1): 222-230
Mahanty, S.; King, C.L.; Kumaraswami, V.; Regunathan, J.; Maya, A.; Jayaraman, K.; Abrams, J.S.; Ottesen, E.A.; Nutman, T.B. 1993: IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. Journal of Immunology 151(7): 3704-3711
Dekruyff, R.H.; Fang, Y.; Umetsu, D.T. 1995: IL-4-Based helper activity of CD4+ T cells is radiation sensitive. Cellular Immunology 160(2): 248-256
Chung, J.; Deutsch, H.H.; Kalthoff, F.S. 1996: IL-4-dependent proliferation of BA/F3 cells expressing a growth-negative mutant of the human IL-4 receptor is restored by enforced expression of Bcl-2. Journal of Leukocyte Biology 59(4): 586-590
Dubois, G.R.; Bruijnzeel, P.L. 1994: IL-4-induced migration of eosinophils in allergic inflammation. Annals of the new York Academy of Sciences 725: 268-273
Cronin, D.C.; Stack, R.; Fitch, F.W. 1995: IL-4-producing CD8+ T cell clones can provide B cell help. Journal of Immunology 154(7): 3118-3127
Leite-De-Moraes, M.C.; Moreau, G.; Arnould, A.; Machavoine, F.; Garcia, C.; Papiernik, M.; Dy, M. 1998: IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. European Journal of Immunology 28(5): 1507-1515
Quentmeier, H.; Kolsdorf, K.; Zaborski, M.; Drexler, H.G. 1995: IL-4R alpha and gamma chain expression in LPS- and IL-4-stimulated MONO-MAC-6 cells. Leukemia 9(2): 336-340
Cai, J.; Zheng, T.; Murphy, J.; Waters, C.A.; Lin, G.Y.; Gill, P.S. 1997: IL-4R expression in AIDS-KS cells and response to rhIL-4 and IL-4 toxin (DAB389-IL-4). Investigational New Drugs 15(4): 279-287
Dieli, F.; Asherson, G.L.; Sireci, G.; Lio, D.; Bonanno, C.T.; Salerno, A. 1995: IL-5 enhances in vitro and in vivo antigen-specific IgA production in MHC genetically determined low IL-5 responder mice. Cellular Immunology 163(2): 309-313
Sato, S.; Katagiri, T.; Takaki, S.; Kikuchi, Y.; Hitoshi, Y.; Yonehara, S.; Tsukada, S.; Kitamura, D.; Watanabe, T.; Witte, O.; Takatsu, K. 1994: IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. Journal of Experimental Medicine 180(6): 2101-2111
Bozza, P.T.; Castro-Faria-Neto, H.C.; Penido, C.; Larangeira, A.P.; Silva, P.M.; Martins, M.A.; Cordeiro, R.S. 1994: IL-5 accounts for the mouse pleural eosinophil accumulation triggered by antigen but not by LPS. Immunopharmacology 27(2): 131-136
Bates, M.E.; Bertics, P.J.; Busse, W.W. 1996: IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. Journal of Immunology 156(2): 711-718
Koike, M.; Takatsu, K. 1994: IL-5 and its receptor: which role do they play in the immune response?. International Archives of Allergy and Immunology 104(1): 1-9
Fujisawa, T.; Terada, A.; Atsuta, J.; Iguchi, K.; Kamiya, H.; Sakurai, M. 1997: IL-5 as a strong secretagogue for human eosinophils. International Archives of Allergy and Immunology 114(Suppl): 81-83
Ochiai, K.; Kagami, M.; Matsumura, R.; Tomioka, H. 1997: IL-5 but not interferon-gamma (IFN-gamma) inhibits eosinophil apoptosis by up-regulation of bcl-2 expression. Clinical and Experimental Immunology 107(1): 198-204
Faccioli, L.H.; Mokwa, V.F.; Silva, C.L.; Rocha, G.M.; Araujo, J.I.; Nahori, M.A.; Vargaftig, B.B. 1996: IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome. Mediators of Inflammation 5(1): 24-31
Jenne, L.; Kilwinski, J.; Scheffold, W.; Kern, P. 1997: IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clinical and Experimental Immunology 109(1): 90-97
Schandené, L.; Namias, B.; Crusiaux, A.; Lybin, M.; Devos, R.; Velu, T.; Capel, P.; Bellens, R.; Goldman, M. 1993: IL-5 in post-traumatic eosinophilic pleural effusion. Clinical and Experimental Immunology 93(1): 115-119
Ohnishi, T.; Kita, H.; Weiler, D.; Sur, S.; Sedgwick, J.B.; Calhoun, W.J.; Busse, W.W.; Abrams, J.S.; Gleich, G.J. 1993: IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. American Review of Respiratory Disease 147(4): 901-907
D'auria, L.; Pietravalle, M.; Mastroianni, A.; Ferraro, C.; Mussi, A.; Bonifati, C.; Giacalone, B.; Ameglio, F. 1998: IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity. Archives of Dermatological Research 290(1-2): 25-27
Mori, A.; Suko, M.; Nishizaki, Y.; Kaminuma, O.; Kobayashi, S.; Matsuzaki, G.; Yamamoto, K.; Ito, K.; Tsuruoka, N.; Okudaira, H. 1995: IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. International Immunology 7(3): 449-457
Tang, C.; Rolland, J.M.; Ward, C.; Quan, B.; Walters, E.H. 1997: IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. European Respiratory Journal 10(3): 624-632
Hitoshi, Y.; Sonoda, E.; Kikuchi, Y.; Yonehara, S.; Nakauchi, H.; Takatsu, K. 1993: IL-5 receptor positive B cells, but not eosinophils, are functionally and numerically influenced in mice carrying the X-linked immune defect. International Immunology 5(9): 1183-1190
Till, S.; Dickason, R.; Huston, D.; Humbert, M.; Robinson, D.; Larché, M.; Durham, S.; Kay, A.B.; Corrigan, C. 1997: IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease. Journal of Allergy and Clinical Immunology 99(4): 563-569
Hoshi, H.; Ohno, I.; Honma, M.; Tanno, Y.; Yamauchi, K.; Tamura, G.; Shirato, K. 1995: IL-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 25(8): 720-728
Wada, K.; Kaminuma, O.; Mori, A.; Nakata, A.; Ogawa, K.; Kikkawa, H.; Ikezawa, K.; Suko, M.; Okudaira, H. 1998: IL-5-producing T cells that induce airway eosinophilia and hyperresponsiveness are suppressed by dexamethasone and cyclosporin A in mice. International Archives of Allergy and Immunology 117(Suppl): 24-27
Watson, C.; Whittaker, S.; Smith, N.; Vora, A.J.; Dumonde, D.C.; Brown, K.A. 1996: IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clinical and Experimental Immunology 105(1): 112-119
Weimann, E.; Reisbach, G.; Reinsberg, J.; Lentze, M.J. 1995: IL-6 and G-CSF levels in amniotic fluid during the second trimester in normal and abnormal pregnancies. Archives of Gynecology and Obstetrics 256(3): 125-130
Rougier, F.; Cornu, E.; Praloran, V.; Denizot, Y. 1998: IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine 10(2): 93-97
Tajika, K.; Ikebuchi, K.; Inokuchi, K.; Hasegawa, S.; Dan, K.; Sekiguchi, S.; Nakahata, T.; Asano, S. 1998: IL-6 and SCF exert different effects on megakaryocyte maturation. British Journal of Haematology 100(1): 105-111
LeVine, S.M.; Brown, D.C. 1997: IL-6 and TNFalpha expression in brains of twitcher, quaking and normal mice. Journal of Neuroimmunology 73(1-2): 47-56
Hisano, S.; Sakamoto, K.; Ishiko, T.; Kamohara, H.; Ogawa, M. 1997: IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field. Cytokine 9(6): 447-452
Doré, P.; Lelièvre, E.; Morel, F.; Brizard, A.; Fourcin, M.; Clemént, C.; Ingrand, P.; Daneski, L.; Gascan, H.; Wijdenes, J.; Gombert, J.; Preud'homme, J.L.; Lecron, J.C. 1997: IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases. Clinical and Experimental Immunology 107(1): 182-188
Björck, P.; Larsson, S.; Andäng, M.; Ahrlund-Richter, L.; Paulie, S. 1998: IL-6 antisense oligonucleotides inhibit IgE production in IL-4 and anti-CD40-stimulated human B-lymphocytes. Immunology Letters 61(1): 1-5
Hibi, M.; Nakajima, K.; Hirano, T. 1996: IL-6 cytokine family and signal transduction: A model of the cytokine system. Journal of Molecular Medicine 74(1): 1-12